homocysteine has been researched along with Chronic Kidney Failure in 392 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (1.02) | 18.7374 |
1990's | 68 (17.35) | 18.2507 |
2000's | 258 (65.82) | 29.6817 |
2010's | 59 (15.05) | 24.3611 |
2020's | 3 (0.77) | 2.80 |
Authors | Studies |
---|---|
Aiello, V; Angelini, A; Capelli, I; Cappuccilli, ML; Cianciolo, G; Croci Chiocchini, AL; Iacovella, F; Magnoni, G; Mancini, R; Napoletano, A; Troiano, A | 1 |
Abolghasemi, R; Afzal, G; Polroudi Moghaddam, M; Sabaghian, T; Saffaei, A; Samadian, F; Sistanizad, M; Ziaie, S | 1 |
Balbino, KP; Bressan, J; Costa, JBS; Hermsdorff, HHM; Juvanhol, LL; Marota, LD; Wendling, AL | 1 |
Capelli, I; Cappuccilli, M; Cianciolo, G; Gasperoni, L; La Manna, G; Tondolo, F; Zappulo, F | 1 |
Larie, HA; Malekmakan, L; Nikoo, MH; Pakfetrat, M; Shahroodi, JR; Zolgadr, AA | 1 |
Bernardini, S; Bocedi, A; Dessì, M; Di Daniele, N; Fabrini, R; Noce, A; Pastore, A; Ricci, G; Rovella, V; Santini, S; Tesauro, M | 1 |
El-Charabaty, E; El-Sayegh, S; Saifan, C | 1 |
Aksamit, D; Janda, K; Krzanowski, M; Kuzniewski, M; Sułowicz, W | 1 |
Savaj, S | 1 |
Dehgan, R; Estakhri, R; Habibi Asl, B; Panahi, F; Purasgar, B; Safaian, A; Tayebi-Khosroshahi, H | 1 |
Anderson-Schmidt, H; Becker, A; Blaschke, S; Cohrs, S; Gade, K; Rodenbeck, A | 1 |
Dessì, M; Di Daniele, N; Di Giovamberardino, G; Noce, A; Pastore, A; Pieri, M; Zenobi, R | 1 |
Bouchenak, M; Kaddous, A; Mekki, K; Messaoudi, A; Tbahriti, HF | 1 |
Ashtiani, MN; Azimi, SZ; Kazemnezhad, E; Khosravi, M; Lebadi, M; Mirzajani, E; Monfared, A | 1 |
Armbruster, FP; Dschietzig, TB; Loitsch, SM; Oremek, GM; Reuter, KC; Stangl, K; Stein, J; Wetzstein, R | 1 |
Abbasian, S; Abdi, K; Babaei, M; Dashti, N; Gerayeshnejad, S; Lamei, N; Nazari, F | 1 |
Akbas, H; Aktas Samur, A; Arici, G; Coskunfirat, N; Davran, F; Ertug, Z; Hadimioglu, N; Ozdemir, B | 1 |
Apaydin, S; Bozabali, S; Dincel, N; Gun, ZH; Mir, S; Özdemir, K; Sozeri, B; Yilmaz, E | 1 |
Ostrakhovitch, EA; Tabibzadeh, S | 1 |
Biniaz, V; Ebadi, A; Einollahi, B; Rahimi, A; Savari, S; Shermeh, MS; Tayebi, A | 1 |
Cass, A; Gallagher, MP; Jardine, MJ; Kang, A; Kulshrestha, S; Navaneethan, SD; Nigwekar, SU; Perkovic, V; Strippoli, GF; Zoungas, S | 1 |
Amin, HK; El-Sayed, MI; Leheta, OF | 1 |
Hou, FF; Huo, Y; Li, Y; Liang, M; Qin, X; Sun, D; Wang, B; Wang, J; Xu, X | 1 |
Cetın, N; Karabel, D; Sav, NM; Yildirim, A; Yıldız, B | 1 |
Andini, R; De Vincentiis, L; Dialetto, G; Durante-Mangoni, E; Iossa, D; Mattucci, I; Molaro, R; Parrella, A; Ursi, MP; Utili, R | 1 |
Borettaz, I; D'angelo, A; Derosa, G; Esposito, P; Libetta, C; Maffioli, P; Tinelli, C | 1 |
Abdel Hamid, SG; El-Mesallamy, HO; Gad, MZ | 1 |
Dierkes, J; Domröse, U; Heinz, J; Luley, C; Neumann, KH; Westphal, S | 1 |
Cho, L; Hazen, SL; Hoogwerf, BJ; Lauer, MS; Oliveira, LP; Shishehbor, MH; Sprecher, DL; Wolski, K | 1 |
Akgul, A; Arat, Z; Bilgic, A; Haberal, M; Ozdemir, FN; Sezer, S | 1 |
Escola, JM; Garcia Gallego, F; Robles, NR; Sanchez Munoz-Torrero, JF; Velasco Gemio, J | 1 |
Bamgbola, OF; Kaskel, FJ | 1 |
Kristofova, B; Valocik, G; Valocikova, I | 1 |
Arenas Jiménez, MD | 1 |
Cabarkapa, V; Ilincić, B; Stosić, Z; Zeravica, R | 1 |
Bennett, PC; Gill, PS; Lip, GY; Silverman, S | 1 |
Li, N; Li, PL; Tang, L; Xia, M; Yi, F; Zhang, C | 1 |
Righetti, M | 1 |
Bali, M; Cengel, A; Güz, G; Mutluay, R; Okyay, K; Sahinarslan, A; Sindel, S; Yalçin, R | 1 |
Abdallah, TB; Boubaker, K; Feki, M; Fellah, H; Hammami, MB; Kaabachi, N; Lacour, B; Mebazaa, A | 1 |
Cutler, MJ; Freeman, DJ; House, AA; Spence, JD; Urquhart, BL | 1 |
Coresh, J; Fox, CS; Muntner, P; Uribarri, J; Vupputuri, S | 1 |
Dierkes, J; Heinz, J; Kropf, S; Luley, C | 1 |
Einollahi, B; Farhangi, S; Farjad, R; Firouzan, A; Kalantar, A; Kardavani, B; Khatami, F; Nafar, M; Pour-Reza-Gholi, F | 1 |
Abe, OA; Basu, P; Givvimani, S; Metreveli, N; Passmore, JC; Sen, U; Shah, KS; Tyagi, N; Tyagi, SC | 1 |
Agrawal, S; Baburaj, VP; Sankhwar, SN; Sharma, RK; Tripathi, G | 1 |
Ahmadinejad, M; Atabak, S; Hedayati, M; Imani, H; Rahmani, L; Tabibi, H | 1 |
Boroumand, MA; Djalali, M; Eshragian, MR; Khatami, MR; Shojaei, MH; Siassi, F | 1 |
Brady, CB; Cxypoliski, RA; Gaziano, JM; Goldfarb, DS; Guarino, PD; Hartigan, P; Jamison, RL; Kaufman, JS; Warren, SR | 1 |
Ates, K; Ertek, S; Torun, AN | 1 |
Abedi, SA; Bohlooli, A; Nakhjavani, MR; Tarzamni, MK | 1 |
Connolly, GM; Cunningham, R; Maxwell, AP; McNamee, PT; Young, IS | 1 |
Gómez-Sánchez, MP; Melero-Rubio, E; Merchán-Mayado, E; Párraga-Díaz, M; Pellicer-Villaescusa, S | 1 |
Chan, CT; Darling, PB; Donnelly, SM; House, JD; Kannampuzha, J; McFarlane, PA; Pencharz, PB | 1 |
Filiopoulos, V; Hadjiyannakos, D; Metaxaki, P; Sideris, V; Takouli, L; Vlassopoulos, D | 1 |
Abdallah, TB; Aderrahim, E; Elyounsi, F; Hamida, FB; Hedri, H; Helal, I; Kheder, A; Maiz, HB; Ouniss, M; Smaoui, W | 1 |
Anees, M; Asghar, A; Ibrahim, M; Mumtaz, A; Shaheen, SM | 1 |
Binici, DN; Borazan, A | 1 |
Borucki, K; Dierkes, J; Domröse, U; Heinz, J; Kropf, S; Luley, C; Neumann, KH; Westphal, S | 1 |
de Koning, L; Hu, FB | 1 |
Dohi, Y; Ito, A; Itoh, T; Kajikuri, J; Koyama, K; Kumagai, H; Nakamura, H; Nishio, T; Ohte, N; Sano, A; Yamamoto, J | 1 |
Himmelfarb, J; McMenamin, ME; Nolin, TD; Ouseph, R; Ward, RA | 1 |
Kolarz, M; Kraśniak, A; Padjas, A; Rogulska, J; Wyroślak, J; Zbróg, Z | 1 |
Aleksandrowicz, E; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Łysiak-Szydłowska, W | 1 |
Atabati, E; Ostovan, MA; Raisjalai, GA; Roozbeh, J; Sagheb, MM; Sohrabi, Z | 1 |
Christensen, JH; Jørgensen, KA; Rasmussen, LE; Schmidt, EB; Svensson, M | 1 |
Chen, Y; Hou, F; Huo, Y; Langman, CB; Matossian, D; Qin, X; Wang, X; Xu, X | 1 |
Bhandari, S | 1 |
Harada, K; Hiraoka, S; Kaji, E; Kato, J; Kuwaki, K; Matsushima, H; Morikawa, T; Saito, S; Tatsukawa, M; Yamamoto, K | 1 |
Bernadeta, M; Danuta, KP; Grażyna, C; Małgorzata, I; Małgorzata, S; Piotr, K; Przemysław, W; Witold, S | 1 |
Candan, F; Güngör, Y; Kayataş, M; Özdemir, Ö; Yıldız, G | 1 |
Ghorbani, R; Jamshidi, L; Malek, F; Malek, M; Soliemani, A; Tamadon, MR | 1 |
Chiarello, PG; Geleilete, TJ; Guerra, DC; Silva de Almeida, CC; Vannucchi, H; Vannucchi, MT | 1 |
Badiou, S; Bargnoux, AS; Canaud, B; Cristol, JP; Dupuy, AM; Jaussent, I; Klouche, K; Leray-Moragues, H; Morena, M; Patrier, L | 1 |
de Haro, T; Ortega, E; Osorio, A; Ruiz-Requena, E; Sánchez, P; Torres, JM | 1 |
Hama, Y; Hasuike, Y; Hazeki, S; Hori, K; Kuragano, T; Nakanishi, T; Nanami, M; Nonoguchi, H; Otaki, Y; Tokuyama, M; Toyoda, K | 1 |
Atzler, D; Böger, RH; Glazer, NL; Lüneburg, N; Maas, R; Riederer, U; Schwedhelm, E; Sullivan, LM; Vasan, RS; Xanthakis, V | 1 |
Chaykovska, L; Hocher, B; Tsuprykov, O | 1 |
Bocedi, A; Dawood, KF; Dessì, M; Fabrini, R; Federici, G; Fucci, G; Galli, F; Manca di Villahermosa, S; Massoud, R; Noce, A; Pastore, A; Ricci, G; Taccone-Gallucci, M; Zingaretti, V | 1 |
Badiou, S; Bargnoux, AS; Bosc, JY; Canaud, B; Chalabi, L; Cristol, JP; Jaussent, I; Leray-Moragues, H; Morena, M; Rodriguez, A | 1 |
Abaterusso, C; Bellinghieri, G; Cirillo, G; Cirillo, M; Coppola, S; De Santo, NG; Di Iorio, B; Ingrosso, D; Lanza, D; Lupo, A; Perna, AF; Raiola, I; Raiola, P; Santoro, D; Satta, E; Savica, V; Sepe, I; Tirino, G; Violetti, E | 1 |
Cai, LL; Guo, LL; Jin, HM; Liu, XL; Pan, Y; Shu, JL; Zhu, XJ | 1 |
Cui, H; Fan, L; Hong, CM; Hu, GL; Hu, YX; Liu, L; Wang, F | 1 |
Jakubowski, H; Perła-Kaján, J | 1 |
Gohari, G; Mahrooz, A; Sedighi, O; Shaygani, H; Zargari, M | 1 |
Liao, MT; Lin, YF; Lo, L; Lu, KC; Wu, CC; Zheng, CM | 1 |
Ding, G; Ma, T | 1 |
Dán, A; Görögh, S; Locsey, L; Szegedi, J; Tóths, E | 1 |
Hoffer, LJ | 3 |
Cheong, HI; Choi, Y; Ha, IS; Hahn, H; Kang, HG; Lee, BS; Lee, JH | 1 |
Delvin, EE; Genest, J; Lambert, M; Merouani, A; Rozen, R | 1 |
Balla, J; Ben, T; Bereczky, Z; Kakuk, G; Kárpáti, I; Katona, E; Mohácsi, A; Muszbek, L; Páll, D; Paragh, G; Szóke, G; Toma, K; Varga, Z | 1 |
Atta, IA; Ben-Yehuda, A; Friedman, G; Goldschmidt, N; Haviv, YS; Shpichinetsky, V | 1 |
Grzeszczak, W; Gumprecht, J; Zukowska-Szczechowska, E; Zychma, MJ | 1 |
Bàràny, P; Bergström, J; Heimbürger, O; Lindholm, B; Stenvinkel, P; Suliman, ME | 1 |
Carluccio, F; Grune, T; Hampl, H; Riedel, E; Siems, W; Sommerburg, O; Stefanelli, G | 1 |
Doulgerakis, C; Karakasis, P; Kountouris, S; Kourvelou, C; Papagalanis, N; Rammos, G; Ziakka, S | 1 |
de Meer, K; Finglas, P; Smulders, Y; Stam, F; Stehouwer, CD; van den Akker, JT | 1 |
Hiraoka, K; Inoue, T; Ishigami, Y; Izumi, M; Nakanishi, T; Otaki, Y; Takamitsu, Y | 1 |
Chowdhury, S; Coleman, JE; Thurlby, D; Wardell, J; Watson, AR | 1 |
Hasuike, Y; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nanami, M; Nishikage, H; Otaki, Y; Takamitsu, Y | 1 |
Brown, EA; Parsons, DS; Pavitt, DV; Reaveley, DA | 1 |
Duan, X; Liu, H; Yao, Y; Zhang, X | 1 |
Hou, F; Hu, M; Yang, L; Yang, Y; Yu, Y; Zhang, X; Zhou, H | 1 |
Fiorini, F; Garibotto, G; Marchelli, M; Rossi, D; Sala, MR; Sofia, A; Verzola, D | 1 |
Chan, JC; Chan, NN; Chan, WB | 1 |
Apeland, T; Brønstad, I; Gøransson, L; Mansoor, MA; Seljeflot, I; Strandjord, RE | 1 |
Bridge, PJ; Fung, E; Hyndman, ME; Manns, BJ; Parsons, HG; Scott-Douglas, NW; Snyder, FF | 1 |
Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G | 1 |
Araki, I; Fukasawa, M; Kamiyama, M; Matsushita, K; Mikami, Y; Takeda, M; Yamagata, Z | 1 |
Hama, Y; Hasuike, Y; Izumi, M; Miyagawa, K; Moriguchi, R; Nakanishi, T; Nanami, M; Nishikage, H; Otaki, Y; Takamitsu, Y | 1 |
Calevo, MG; Canepa, A; Canini, S; Caridi, G; Carrea, A; Cerone, R; Dertenois, L; Minniti, G; Perfumo, F | 1 |
Haynes, WG | 1 |
Baranowicz-Gaszczyk, I; Bednarek-Skublewska, A; Buraczyńska, M; Ksiazek, A; Wawrzycki, S | 1 |
Donker, AJ; Schalkwijk, CG; Stam, F; Stehouwer, CD; ter Wee, PM; van Guldener, C | 1 |
Massy, ZA | 2 |
Landray, MJ; Townend, JN; Wheeler, DC | 1 |
Beddhu, S; Herzog, CA; Logar, CM | 1 |
Cohen, BD | 1 |
Dierkes, J; Födinger, M; Hagen, W; Hauser, AC; Puttinger, H; Röhrer, C; Skoupy, S; Sunder-Plassmann, G; Vychytil, A | 1 |
Chmiel, G; Czarnecka, D; Drozdz, M; Gozdecka, H; Kowalczyk-Michałek, M; Kraśniak, A; Małczak, J; Miłkowski, A; Moskal, K; Podwysocki, A; Sułowicz, W; Sydor, A; Szczeklik, A; Szmigielski, M; Wiecek, A; Zabawa-Hołyś, S | 1 |
Chiarello, PG; Vannucchi, H; Vannucchi, MT | 1 |
Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
Hörl, WH | 1 |
Ben Abdallah, T; Ben Maiz, H; Feki, M; Fellah, H; Hsairi, M; Kaabachi, N; Lacour, B; Massy, ZA; Mebazaa, A; Sanhaji, H | 1 |
Kortas, C; Lindsay, RM; Moist, L; Nesrallah, G; Suri, R | 1 |
Benedetti, S; Buoncristiani, E; Buoncristiani, U; Canestrari, F; Conte, C; Floridi, A; Galli, F; Piroddi, M | 1 |
de Gómez Dumm, NT; Giammona, AM; Touceda, LA | 1 |
Minagawa, T; Oda, H; Ohashi, H; Ohkuma, T; Ohno, M; Takada, N | 1 |
Födinger, M; Hagen, W; Hauser, AC; Puttinger, H; Röhrer, C; Skoupy, S; Sunder-Plassmann, G; Veitl, M; Vychytil, A; Wojcik, J | 1 |
Andersen, CB; Bentzon, JF; Bro, S; Falk, E; Nielsen, LB; Olgaard, K | 1 |
Dal Canton, A; Guidetti, C; Libetta, C; Rossi, N; Sepe, V | 1 |
Födinger, M; Konner, P; Müllner, M; Pleiner, J; Röhrer, C; Skoupy, S; Sunder-Plassmann, G; Vychytil, A; Wolzt, M | 1 |
Bernard, D; Boelaert, JR; De Vriese, AS; Geerolf, I; Langlois, M; Matthys, E; Schurgers, M; Stevens, L | 1 |
Liu, H; Peng, YM; Wang, HT | 1 |
Stehouwer, CD; van Guldener, C | 2 |
Atkins, RC; Branley, P; Kerr, PG; McGrath, BP; McNeil, JJ; Polkinghorne, KR; Villanueva, E; Zoungas, S | 1 |
García-Idoate, G; Mora, C; Muros, M; Navarro, JF | 1 |
Beige, J; Riezler, R; Rinder, C; Scholze, A; Tepel, M; Zidek, W | 1 |
Chiarello, PG; Moysés Neto, M; Vannucchi, H; Vannucchi, MT | 1 |
Robinson, K | 1 |
Coplon, NS; Fortmann, SP; Hornberger, JM; McCann, LM; Wrone, EM; Zehnder, JL | 1 |
Forrester, M; Freixas, EA; Pereyra, H; Schropp, J; Trimarchi, H | 1 |
Endreffy, E; Karg, E; Maróti, Z; Németh, I; Túri, S; Ugocsai, P | 1 |
Hou, FF; Liu, ZQ; Yu, YM; Zhang, X; Zhou, H | 1 |
Eberle, C; Feix, A; Födinger, M; Sunder-Plassmann, G; Winkelmayer, WC | 1 |
Casciani, S; Cortese, C; De Angelis, S; Dessì, MR; Federici, G; Ferranini, M; Liberatoscioli, L; Pastore, A; Splendiani, G; Tullio, T | 1 |
Falcinelli, F; Floridi, A; Gresele, P; Imperiali, P; Migliacci, R; Nenci, GG | 1 |
Aras, O; Arends, VL; Hanson, NQ; Hunninghake, DB; Matas, AJ; Sozen, H; Tsai, MY; Woll, PS | 1 |
Busch, M; Franke, S; Gerth, J; Müller, A; Niwa, T; Ott, U; Stein, G; Wolf, M | 1 |
Huhtala, H; Lehtimäki, T; Leskinen, Y; Loimaala, A; Oja, SS; Saha, H; Salenius, JP | 1 |
de Meer, K; Jakobs, C; Kulik, W; Smith, DE; Stam, F; Stehouwer, CD; ter Wee, PM; van Guldener, C | 1 |
Ben Abdallah, T; Ben Maiz, H; Feki, H; Feki, M; Fellah, H; Kaabachi, N; Lacour, B; Massy, ZA; Mebazaa, A; Souissi, M | 1 |
Eliasziw, M; Freeman, DJ; House, AA; Spence, JD; Urquhart, BL | 1 |
Bald, E; Czupryniak, A; Kałuzyńska, A; Nowicki, M; Owczarek, D; Wiecek, B | 1 |
Tepel, M; Zidek, W | 1 |
Chambers, ST; George, PM; Lee, MB; Lever, M; McGregor, DO; Slow, S | 1 |
Herrmann, W; Köhler, H; Kuhlmann, MK; Obeid, R | 1 |
Chandraker, A; Curhan, GC; Endler, G; Födinger, M; Hörl, WH; Kramar, R; Sunder-Plassmann, G; Winkelmayer, WC | 1 |
De Bacquer, D; De Vriese, AS; Delanghe, JR; Geerolf, I; Lameire, NH; Langlois, M; Stevens, L; Taes, YE | 1 |
Chu, PL; Chu, TS; Hsu, SP; Huang, JW; Shih, KY; Wu, KD; Yang, SY | 1 |
Bowden, RG; Gentile, M; Wilborn, C; Wilson, R; Wyatt, FB | 1 |
de Meer, K; Jakobs, C; Stam, F; Stehouwer, CD; Ter Wee, PM; van Guldener, C | 1 |
Herrmann, W; Kirsch, CM; Kuhlmann, M; Obeid, R | 1 |
Battaglia, G; Garozzo, M; Milone, F; Urso, S | 1 |
Canaud, B; Chalabi, L; Cristol, JP; Desmeules, S; Krieter, D; Lévesque, R; Moragués, H; Morena, M | 1 |
Cases, A | 1 |
Aydemir, S; Borazan, A; Sert, M; Yilmaz, A | 1 |
Fowler, B; Herrmann, W; Kuhlmann, MK; Makowski, J; Obeid, R; Schorr, H | 1 |
Beck, GJ; Greene, T; Kusek, JW; Levey, AS; Menon, V; Sarnak, MJ; Selhub, J; Wang, X | 1 |
Chan, IH; Lam, CW; Li, PK; Lui, SF; Sanderson, JE; Wang, AY; Wang, M; Woo, J | 1 |
Agarwal, V; Arzaghi, J; Baldo, DB; Benner, D; Braglia, A; Bross, R; Chow, J; Colman, S; Dennis, J; Kalantar-Zadeh, K; Khawar, OS; Martinez, B; Martinez, L; Trundnowski, T; Zitterkoph, J | 1 |
Fiedler, R; Mall, M; Osten, B; Wand, C | 1 |
Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
Barré, PE; Golden, M; Hoffer, LJ; Saboohi, F | 1 |
Malberti, F; Mallamaci, F; Ravani, P; Testa, S; Tripepi, G; Zoccali, C | 1 |
Ward, RA | 1 |
Bauer, DC; Jamal, SA; Leiter, RE | 1 |
Gausset, P; Vanderpas, J; Wolff, F | 1 |
Campbell, SB; Hawley, CM; Hollett, P; Isbel, NM; Johnson, DW; Law, B; Mudge, DW; Petrie, JJ; Price, L; Reiger, K; Rogers, R; Sullivan, M | 1 |
Alvarez González, A; Delgado, P; Hernández, D; Lorenzo, V; Pérez Tamajón, L; Sánchez Alvarez, JE | 1 |
Abbate, R; Bandini, S; Barsotti, G; Bergesio, F; Castrignano, E; Ciuti, R; Cristofano, C; Cupisti, A; Gallo, M; Gallucci, M; Guasparini, A; Marcucci, R; Monzani, G; Salvadori, M; Tosi, PL | 1 |
Chang, JM; Chen, HC; Chiu, YW; Chuang, HY; Hwang, SJ; Kuo, HT; Lai, YH; Tsai, JC | 1 |
Bourgouin, PE; Djahangirian, O; Eid, J; Hoffer, LJ; Saboohi, F | 1 |
Zoccali, C | 1 |
Allajar, D; Nanayakkara, PW; Schalkwijk, C; Spijkerman, A; Stehouwer, CD; Teerlink, T; ter Wee, PM; van Guldener, C | 1 |
Duan, S; Liu, F; Liu, H; Liu, Y; Peng, Y; Wang, H | 1 |
Cesari, M; Pessina, AC; Rossi, GP | 1 |
Fortmann, SP; Gaziano, JM; Goldfarb, DS; Haroldson, JA; Hartigan, P; Jamison, RL; Kaufman, J; Lavori, P; McCully, KS; Robinson, K | 1 |
Födinger, M; Hörl, WH; Puttinger, H; Rutkowski, B; Rutkowski, P; Strozecki, P; Tylicki, L; Tyszko, S | 1 |
Nubé, MJ; Nurmohamed, SA | 1 |
Fort, J | 1 |
Farkouh, ME; Geer, EB; Halperin, JL; Kim, M; Nair, AP; Nemirovsky, D; Robbins, MJ; Winston, J | 1 |
Alvestrand, A; Anderstam, B; Sjöberg, B; Suliman, M | 1 |
Casciani, S; Cortese, C; De Angelis, S; Dessi', M; Di Giovamberardino, G; Federici, G; Noce, A; Pastore, A; Ruggia, R; Splendiani, G | 1 |
Mallamaci, F; Zoccali, C | 1 |
Bárány, P; Lindholm, B; Rashid Qureshi, A; Stenvinkel, P; Suliman, ME | 1 |
Díaz, ML; Forrester, M; Freixas, E; Schropp, J; Trimarchi, H; Young, P | 1 |
Chiarello, PG; Cuppari, L; Draibe, SA; Feiten, SF; Nerbass, FB; Vannucchi, H | 1 |
van Guldener, C | 2 |
Bayram, C; Bekpinar, S; Cetin, O; Turkmen, A; Ulutin, T; Unlucerci, Y | 1 |
Jacobsen, DW | 2 |
Chaiyasoot, W; Chanchairujira, T; Leowattana, W; Ong-Ajyooth, L; Ong-Ajyooth, S; Shayakul, C; Sritippayawan, S; Taruangsri, P; Vanichakarn, S; Vareesangthip, K; Vasuvattakul, S | 1 |
Ferrario, GM; Milani, S; Righetti, M; Serbelloni, P; Tommasi, A | 1 |
Armstrong, KA; Isbel, NM; Johnson, DW; Leano, R; Marwick, TH; Rakhit, DJ | 1 |
Djukanovic, L; Jemcov, T; Novakovic, I; Pejanovic, S; Radovic, M; Simic-Ogrizovic, S; Stosovic, M | 1 |
Bernasconi, AR; Del Pino, N; Heguilén, RM; Liste, A; Rosa Diez, GJ | 1 |
Verbeelen, DL | 1 |
Ferrario, G; Milani, S; Righetti, M; Serbelloni, P | 1 |
Altintepe, L; Demir, M; Güney, I; Tonbul, HZ; Türk, S; Yeksan, M; Yeter, E; Yildiz, A | 1 |
Aksoy, Y; Aydogdu, I; Kosar, F; Sahin, I; Senel, S; Taskapan, H; Taskapan, MC; Ulutas, O | 1 |
Kes, P; Lovcić, V; Reiner, Z | 1 |
Anzaldi, M; Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS | 1 |
Kozłowska, I | 1 |
Badiou, S; Canaud, B; Cristol, JP; Delcourt, C; Dupuy, AM; Jaussent, I; Leray-Moragues, H; Maurice, F; Naudin, E; Rivory, JP; Terrier, N | 1 |
Fukuzawa, J; Hasebe, N; Kikuchi, K; Koyama, S; Yao, N | 1 |
Bostom, AG; Carpenter, MA; Hunsicker, LG; Jacques, PF; Kusek, JW; Levey, AS; McKenney, J; Pfeffer, MA | 1 |
Kes, P; Kusec, V; Lovcić, V; Zeljko, R | 1 |
Bárány, P; Heimbürger, O; Kalantar-Zadeh, K; Lindholm, B; Qureshi, AR; Stenvinkel, P; Suliman, M; Vonesh, EF | 1 |
Böger, CA; Christ, J; Götz, AK; Haak, T; Hoffmann, U; Krämer, BK; Riegger, GA; Stubanus, M | 1 |
Jakubowski, H; Undas, A | 1 |
Chaiyasoot, W; Chanchairujira, T; Leowattana, W; Ong-ajyooth, L; Ong-ajyooth, S; Shayakul, C; Sritippayawan, S; Tungkasereerak, P; Vareesangthip, K; Vasuvattakul, S | 1 |
Hishida, A; Ikegaya, N; Kato, A; Kumagai, H; Maruyama, Y; Sakurai, M; Takita, T; Uno, S | 1 |
Thaha, M; Tomino, Y; Yogiantoro, M | 1 |
Bárány, P; Heimbürger, O; Jogestrand, T; Lindholm, B; Maruyama, Y; Qureshi, AR; Stenvinkel, P; Suliman, ME | 1 |
Freeman, DJ; House, AA; Spence, JD; Urquhart, BL | 1 |
Movilli, E | 1 |
Nanayakkara, PW; Scheffer, PG; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Dorp, W; van Guldener, C; van Ittersum, FJ | 1 |
Alberghini, E; Baragetti, I; Buccianti, G; Buzzi, L; Catapano, AL; Furiani, S; Garlaschelli, K; Raselli, S; Stucchi, A; Terraneo, V | 1 |
Marcus, J; Menon, V; Sarnak, MJ | 1 |
Degtereva, OA; Menshutina, MA; Panina, IIu; Petrishchev, NN; Rumiantsev, ASh; Smirnov, AV; Tugusheva, FA | 1 |
Adamo, G; Dal Canton, A; Giuliano, MG; Libetta, C; Sepe, V | 1 |
Gaziano, JM; Goldfarb, DS; Guarino, PD; Hartigan, P; Jamison, RL; Kaufman, JS; Warren, SR | 1 |
Nanayakkara, PW; Stehouwer, CD; van Guldener, C | 1 |
Barbara, JA; Hewitson, CL; Mangoni, AA; Whiting, MJ | 1 |
Aki, TF; Bakkaloglu, A; Bakkaloglu, M; Basaran, C; Besbas, N; Bilginer, Y; Duzova, A; Karabulut, E; Ozaltin, F; Ozen, S; Topaloglu, R | 1 |
Li, PL; Yi, F | 1 |
Arnold, JM; Fodor, G; Held, C; Lonn, EM; Mann, JF; McQueen, MJ; Sheridan, P; Yusuf, S | 1 |
Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
De Angelis, S; Diana, L; Palleschi, S; Papa, V; Rossi, B; Severini, G; Splendiani, G | 1 |
Chua, B; Flood, V; Mitchell, P; Rochtchina, E; Shankar, A; Wang, JJ | 1 |
do Nascimento, MM; Hayashi, SY; Lindholm, B; Manfro, RC; Pachaly, MA; Riella, MC; Stenvinkel, P; Suliman, ME | 1 |
Blom, HJ; Kiefte-de Jong, JC; Kok, RM; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; ter Wee, PM; van Guldener, C; van Ittersum, FJ | 1 |
Beavers, DP; Beavers, KM; Bowden, RG; Gentile, M; Wilson, RL | 1 |
Cutler, MJ; Freeman, DJ; House, AA; Mainra, R; Spence, JD; Urquhart, BL | 1 |
Birn, H | 1 |
Baptista, AP; Bernardo, I; Cabrita, A; Cacdocar, S; Carrasqueira, H; Faísca, M; Gome, V; Morgado, E; Neves, PL; Palmeiro, H; Sampaio, S; Silva, AP | 1 |
Bahner, U; Brink, A; Heidland, A; Perna, A; Schmid, U; Schupp, N; Stopper, H; Treutlein, AT | 1 |
Gupta, VJ; Reddy, SG; Wilcken, DE | 1 |
Bostom, A; Brosnan, JT; Hall, B; Nadeau, MR; Selhub, J | 1 |
Dwyer, JT; Friedman, JA | 1 |
Bostom, AG; Hartman, W; Lapane, KL; Miller, JW; Nadeau, M; Prior, R; Seyoum, E; Shemin, D; Sutherland, P; Wilson, PW | 1 |
Andersson, A; Arnadottir, M; Hultberg, B | 1 |
Allen, RH; Bostom, AG; Nadeau, MR; Selhub, J; Shemin, D; Shih, V; Stabler, SP | 1 |
Boers, GH; Janssen, MJ; Stehouwer, CD; van den Berg, M | 1 |
Bader, CA; Chadefaux-Vekemans, B; Chevalier, A; Drüeke, TB; Kamoun, P; Kreis, H; Lacour, B; Legendre, C; Massy, ZA | 1 |
Boers, GH; Janssen, MJ; Stehouwer, CD; van den Berg, M; van Guldener, C | 1 |
Andersson, A; Hultberg, B; Sterner, G | 1 |
Bostom, AG; Brosnan, JT; Hall, B; Nadeau, MR; Selhub, J | 1 |
Bostom, AG; Fisher, DH; Nadeau, MR; Selhub, J; Shemin, D; Yoburn, D | 1 |
Aupetit, J; Chadefaux, B; Chauveau, P; Coudé, M; Jungers, P; Kamoun, P | 1 |
Claus, R; Hausmann, S; Holdt, B; Holtz, M; Knippel, M; Korten, G; Lehmann, JK | 1 |
Bostom, AG; Chan, J; Jacques, PF; Lapane, KL; Nadeau, MR; Rosenberg, IH; Rozen, R; Selhub, J; Shemin, D; Sutherland, P; Yoburn, D | 1 |
Bausserman, L; Bostom, AG; Jacques, PF; Lapane, KL; Nadeau, MR; Rosenberg, IH; Selhub, J; Shemin, D; Sutherland, P; Tofler, G; Wilson, PW; Yoburn, D | 1 |
De Santo, NG; Galletti, P; Ingrosso, D; Perna, AF; Zappia, V | 1 |
Arheart, K; Chaudhary, D; Dennis, V; Green, R; Gupta, A; Jacobsen, DW; Kutner, M; Mayer, EL; Robinson, K; Selhub, J; Vigo, P | 1 |
Dennis, VW; Robinson, K | 1 |
Bergman, SM; Johnston, KE; Tamura, T | 1 |
Zidek, W | 1 |
Bostom, AG; Lathrop, L | 1 |
Guttormsen, AB; Refsum, H; Svarstad, E; Ueland, PM | 1 |
Dennis, VW; Nurko, S; Robinson, K | 1 |
Bianchi, LA; Bostom, AG; Gohh, RY; Hopkins-Garcia, BJ; Jacques, PF; Nadeau, MR; Rosenberg, IH; Selhub, J; Tsai, MY | 1 |
Bottiglieri, T; Lowenthal, D; Parnetti, L | 1 |
Aupetit, J; Bandin, O; Chadefaux, B; Chauveau, P; Descamps-Latscha, B; Jungers, P; Kamoun, P; Labrunie, M | 1 |
De Santo, NG; Ingrosso, D; Perna, AF | 1 |
Bostom, AG; Dworkin, L; Jacques, PF; Nadeau, MR; Rosenberg, IH; Selhub, J; Shemin, D; Verhoef, P | 1 |
Arheart, KL; Dennis, VW; Gupta, A; Jacobsen, DW; Moustapha, A; Nahlawi, M; Naso, A; Robinson, K | 1 |
Bianchi, LA; Bostom, AG; Dworkin, L; Gohh, RY; Hopkins-Garcia, BJ; Jacques, PF; Nadeau, MR; Rosenberg, IH; Selhub, J; Shemin, D; Verhoef, P | 1 |
Hirose, S; Isoda, K; Itakura, Y; Kim, S; Matsuda, A; Matsumura, O; Mitarai, T; Nagasawa, R; Tamura, H | 1 |
Angst, CP; Brunner, FP; Fowler, B; Haefeli, WE; Loehrer, FM | 1 |
Blacher, J; Demuth, K; Guerin, AP; London, GM; Moatti, N; Safar, ME | 1 |
Bronzwaer, JG; Donker, AJ; Jakobs, C; Janssen, MJ; Stehouwer, CD; Surachno, J; van Guldener, C | 1 |
Bergman, SM; Morgan, SL; Tamura, T | 1 |
de Meer, K; Donker, AJ; Jakobs, C; Stehouwer, CD; Teerlink, T; van Guldener, C | 1 |
Donker, AJ; Janssen, MJ; Lambert, J; Stehouwer, CD; Steyn, M; van Guldener, C | 1 |
Chang, SK; Hong, SY; Yang, DH | 2 |
Wanner, C; Zimmermann, J | 1 |
Arnadottir, M; Dimény, E; Fellström, B; Hultberg, B; Wahlberg, J | 1 |
Magott, M | 1 |
Bansal, VK; Beto, JA | 1 |
Chantrel, F; Hannedouche, TP; Kunz, K; Muller, S | 1 |
Burgess, ED; Hyndman, ME; Manns, BJ; Parsons, HG; Schaefer, JP; Scott-Douglas, NW | 2 |
Brulez, HF; Donker, AJ; ter Wee, PM; van Guldener, C | 1 |
Duran, M; Lilien, M; Poll-The, BT; Schröder, C; Van Hoeck, K | 1 |
Ambrosch, A; Bosselmann, HP; Dierkes, J; Domröse, U; Luley, C; Neumann, KH | 1 |
de Meer, K; Donker, AJ; Janssen, MJ; Stehouwer, CD; van Guldener, C | 1 |
Dubois, J; Genest, J; Lambert, M; Merouani, A; Mitchell, GA; Robitaille, P; Rozen, R | 1 |
Arheart, K; Dennis, VW; Gupta, A; Jacobsen, DW; Moustapha, A; Robinson, K; Schreiber, MJ | 1 |
Födinger, M; Hörl, WH; Papagiannopoulos, M; Sunder-Plassmann, G; Vychytil, A; Wölfl, G | 1 |
Ambrosch, A; Dierkes, J; Domröse, U; Guttormsen, AB; Luley, C; Neumann, KH; Schneede, J | 1 |
Landray, MJ; Martin, S; Martin, U; Townend, JN; Wheeler, DC | 1 |
Cordy, P; Freeman, D; Kortas, C; Spence, JD | 1 |
Chang, SK; Choi, JS; Ha, KS; Hong, SY; Lee, HA; Yang, DH | 1 |
Alaupovic, P; Attman, PO; Knight-Gibson, C; Larsson, R; Lee, DM; Mulec, H; Mullen, JK; Samuelsson, O; Weiss, L | 1 |
Berger, R; De Meer, K; Dijkstra, DA; Donker, AJ; Jakobs, C; Kulik, W; Reijngoud, DJ; Stehouwer, CD; van Guldener, C | 1 |
Bresson-Vautrin, C; Chalopin, JM; Ducloux, D | 1 |
Graefe, U; Henning, BF; Langer, K; Raidt, H; Riezler, R; Tepel, M; Zidek, W | 1 |
Accinni, R; Catena, FB; De Vecchi, AF; Patrosso, C | 1 |
Bostom, AG | 1 |
Hirose, S; Isoda, K; Kim, S; Kono, R; Mitarai, T; Shimoyama, H | 1 |
Donker, AJ; Lambert, J; Stehouwer, CD; ter Wee, PM; van Guldener, C | 1 |
Bank, I; Barré, PE; Bercovitch, DD; Davidman, M; Hoffer, LJ; Hongsprabhas, P; Saboohi, F; Shrier, I | 1 |
Gejyo, F; Kimura, H; Miyazaki, R; Suzuki, S | 1 |
Ellgass, A; Herrmann, W; Kiessig, ST; Molinari, E; Quast, S; Riegel, W; Wolter, K | 1 |
Dudman, NP; Fu, W; Perry, MA; Wang, XL; Young, K | 1 |
Fukuda, S; Ichikawa, H; Makino, H; Nagake, Y; Oishi, K; Ota, K; Yamasaki, H | 1 |
Fiedor, P; Polakowska, MJ; Socha, MW; Socha-Urbanek, K | 1 |
Biasioli, S; Schiavon, R | 1 |
Lynn, K; McGregor, D; Shand, B | 1 |
Bonnardeaux, A; Busque, L; Geadah, D; Leblanc, M; Lebrun, M; Ouimet, D; Tremblay, R | 1 |
Clague, A; Healy, H; Morgan, C; Reith, D; Westhuyzen, J | 1 |
Jones, HJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC | 1 |
Baigent, C; Burbury, K; Wheeler, D | 1 |
Gonin, J; Kitiyakara, C; Massy, Z; Wilcox, CS | 1 |
Benedetto, FA; Fermo, I; Focà, A; Malatino, LS; Mallamaci, F; Paroni, R; Tripepi, G; Zoccali, C | 1 |
Robinson, K; van Guldener, C | 1 |
Graefe, U; Henning, BF; Tepel, M; Zidek, W | 1 |
Ambrosch, A; Bosselmann, HP; Dierkes, J; Domröse, U; Luley, C; Neumann, KH; Westphal, S | 1 |
Zucchelli, P | 1 |
Gejyo, F; Kimura, H; Miyazaki, R; Suzuki, S; Takeda, T; Yoshida, H | 1 |
Födinger, M; Sunder-Plassmann, G; Winkelmayer, WC | 1 |
Kohlman-Trigoboff, D; Molina, H; Moore, J; Phillips, J; Smith, BM; Stanford, JL | 1 |
Geadah, D; Leblanc, M; Ouimet, D; Pichette, V | 1 |
Bang, BK; Bostom, AG; Dwyer, JT; Han, H; Jacques, PF; Kim, YS; Park, JH; Selhub, J | 1 |
Chi, HS; Jung, HH; Kim, SB; Min, WK; Park, JS; Yang, WS | 1 |
Gerhardt, U; Hohage, H; Rahn, KH; Suwelack, B; Witta, J | 1 |
Kaysen, GA; Yeun, JY | 1 |
Bank, I; Elian, KM; Hoffer, LJ; Hongsprabhas, P; Mamer, OA; Robitaille, L | 1 |
Stam, F; Stehouwer, CD; van Guldener, C | 1 |
Al-Ahmad, A; Konstam, MA; Salem, DN; Sarnak, MJ | 1 |
Case, C; Fathi, R; Isbel, N; Johnson, D; Kennedy, R; Marwick, TH | 1 |
Cattaneo, M | 1 |
Bukowska, H; Dziewanowski, K; Klinke, M; Naruszewicz, M; Staniewicz, A | 1 |
Bersier, LF; Boulat, O; Descombes, E; Fellay, G | 1 |
Hoffer, LJ; Kaplan, LN; Mamer, OA | 1 |
Hung, WR; Lim, PS; Wei, YH | 1 |
Bosselmann, KP; Dierkes, J; Domröse, U; Luley, C; Neumann, KH | 1 |
Brzósko, S; Hryszko, T; Małyszko, J; Myśliwiec, M | 1 |
Bousquet, B; Gamra, S; Gourmel, B; Houze, P; Madelaine, I | 1 |
Kes, P | 1 |
Chambers, ST; Dellow, WJ; George, PM; Lever, M; McGregor, DO; Robson, RA | 1 |
Lambert, LA; Sarkar, PK | 1 |
Graefe, U; Henning, BF; Riezler, R; Tepel, M; Zidek, W | 1 |
Buchmayer, H; Födinger, M; Heinz, G; Hörl, WH; Kletzmayr, J; Papagiannopoulos, M; Perschl, A; Sunder-Plassmann, G; Vychytil, A | 1 |
Barbara, JA; McDonald, SP; Tallis, GA; Whiting, MJ | 1 |
Haraki, T; Hirai, J; Inazu, A; Kajinami, K; Kawashiri, M; Kitoh, C; Koizumi, J; Mabuchi, H; Shimada, T; Takegoshi, T; Wakasugi, T | 1 |
Baigent, C; Jones, HJ; Kendall, MJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC | 1 |
Nakanishi, T; Takamitsu, Y | 1 |
Düsing, R; Fimmers, R; Hertfelder, HJ; Lottermoser, K; Petras, S; Pöge, U; Schiermeyer, B; Vetter, H | 1 |
Brensing, KA; Frotscher, U; Hages, M; Lütjohann, D; Pietrzik, K; Sigit, JI; von Bergmann, K | 1 |
Delvin, EE; Genest, J; Lambert, M; Merouani, A; Robitaille, P; Rozen, R | 1 |
Födinger, M; Hagen, W; Hörl, WH; Sunder-Plass-Mann, G | 1 |
Haneda, T; Ishida, H; Kikuchi, K; Morimoto, K; Okamoto, K | 1 |
Bankson, DD; Coburn, SP; Lindner, A; Mahuren, JD; Stehman-Breen, C | 1 |
Bellanuova, I; Benedetto, FA; Cataliotti, A; Fermo, I; Malatino, LS; Mallamaci, F; Soldarini, A; Tripepi, G; Zoccali, C | 1 |
Himmelfarb, J; McMenamin, E; McMonagle, E | 1 |
De Vriese, AS; Lameire, NH; Schrijvers, BF; Verbeke, F | 1 |
Goligorsky, MS; Li, H | 1 |
Bennett-Richards, K; Deanfield, JE; Donald, A; Kattenhorn, M; Oakley, G; Rees, L; Varghese, Z | 1 |
Födinger, M; Hörl, WH; Perschl, A; Puttinger, H; Röhrer, C; Schindler, K; Skoupy, S; Sunder-Plassmann, G; Veitl, M; Vychytil, A | 1 |
Funamizu, M; Hata, A; Hayashi, K; Hiejima, Y; Hirayama, H; Kawabata, M; Makita, Y; Nakamura, T; Saionji, K; Tago, K; Tajiri, M; Takano, H | 1 |
Adamczak, M; Chudek, J; Domagała, B; Ignacy, W; Kania, M; Kokot, F; Rutkowski, B; Szczeklik, A; Wiecek, A; Łysiak-SzydŁowska, W | 1 |
Abdel-Raheem, MM; Danielson, BD; Hebert, B; Koka, VK; Potti, A | 1 |
Castañon, M; Diaz, ML; Freixas, E; Genoud, V; Kordich, L; Martino, D; Pereyra, H; Schiel, A; Schropp, J; Trimarchi, H | 1 |
Dvorsak, B; Ekart, R; Gorenjak, M; Hojs, R; Pecovnik-Balon, B | 1 |
Clermont, MJ; Genest, J; Merouani, A; Rozen, R | 1 |
Elian, KM; Hoffer, LJ | 1 |
Costimba, I; Delaportas, N; Georgalidis, C; Kaliolia, I; Karaliotas, G; Katsarou, A; Klonou, E; Koulouridis, E; Krokida, A; Lachanas, A; Panagiotaki, E; Tzilianos, M | 1 |
Gupta, VJ; Wilcken, DE | 1 |
Aupetit, J; Chadefaux, B; Chauveau, P; Coudé, M; Hannedouche, T; Jungers, P; Kamoun, P | 1 |
Chadefaux, B; Coudé, M; Gaillard, O; Kamoun, P; Soria, C | 1 |
Dudman, NP; Robertson, MR; Tyrrell, PA; Wilcken, DE | 1 |
Booth, EM; Mallick, NP; Milewczyk, BK; Robins, AJ | 1 |
73 review(s) available for homocysteine and Chronic Kidney Failure
Article | Year |
---|---|
The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.
Topics: Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Dialysis; Vitamin B 12 | 2021 |
Folic Acid and Vitamin B12 Administration in CKD, Why Not?
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors; Vitamin B 12 | 2019 |
Homocysteine in Chronic Kidney Disease.
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylation; Oxidation-Reduction; Oxidative Stress | 2015 |
Interventions for lowering plasma homocysteine levels in dialysis patients.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Stroke; Venous Thrombosis; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2016 |
Cardiac biomarkers and chronic renal diseases.
Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin | 2008 |
[Updates in hemodialysis].
Topics: Biomarkers; Cardiovascular Diseases; Comorbidity; Endothelium, Vascular; Hemodiafiltration; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Lipoprotein(a); Malnutrition; Online Systems; Oxidative Stress; Quality Indicators, Health Care; Renal Dialysis; Thyroid Diseases | 2008 |
Ethnicity and peripheral artery disease.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Black People; Dyslipidemias; Glucose Metabolism Disorders; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Middle Aged; Peripheral Vascular Diseases; Prevalence; Risk Factors; Smoking; United Kingdom | 2009 |
Protective effect of vitamin B therapy on bone and cardiovascular disease.
Topics: Bone Diseases; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Vitamin B Complex | 2009 |
Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Prospective Studies; Renal Dialysis; Retrospective Studies; Risk Factors; Vitamin B 12 | 2009 |
Homocysteine lowering in end-stage renal disease: is there any cardiovascular benefit?
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic | 2010 |
Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Supplements; Evidence-Based Medicine; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Patient Selection; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Risk Factors; Treatment Outcome | 2011 |
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease.
Topics: Albuminuria; Anemia, Iron-Deficiency; Calcium Phosphates; Carnitine; Heart Failure; Homocysteine; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism Disorders; Myocarditis; Oxidative Stress; Proteinuria; Risk Factors; Vitamin D Deficiency | 2011 |
Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.
Topics: alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Comorbidity; Dyslipidemias; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homocysteine; Humans; Infections; Inflammation; Interleukin-6; Kidney Failure, Chronic; Malnutrition; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proteomics; Renal Replacement Therapy; Troponin T | 2011 |
Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Randomized Controlled Trials as Topic | 2012 |
Paraoxonase 1 and homocysteine metabolism.
Topics: Alzheimer Disease; Animals; Aryldialkylphosphatase; Atherosclerosis; Coronary Artery Disease; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipoproteins, HDL; Mice; Oxidative Stress; Stroke | 2012 |
Role of homocysteine in end-stage renal disease.
Topics: Animals; Dialysis; Homocysteine; Humans; Hyperglycemia; Hyperhomocysteinemia; Kidney; Kidney Failure, Chronic; Meta-Analysis as Topic; Renal Dialysis | 2012 |
Methods for measuring sulfur amino acid metabolism.
Topics: Amino Acids, Sulfur; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kinetics; Methionine; Methylation; Models, Biological; Radioisotope Dilution Technique; Vitamin B 12 | 2002 |
In vivo stable isotope measurements of methyl metabolism: applications in pathophysiology and interventions.
Topics: Deuterium Oxide; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Infusions, Intravenous; Kidney Failure, Chronic; Methionine; Methylation; Serine; Tomography, Emission-Computed; Tritium | 2002 |
Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins.
Topics: Arteriosclerosis; Avitaminosis; Coronary Disease; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Failure, Chronic; Methionine; Risk Factors; Thrombosis; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency; Vitamins | 2002 |
Potential strategies to normalize the levels of homocysteine in chronic renal failure patients.
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Uremia | 2003 |
Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations.
Topics: Antihypertensive Agents; Calcium; Coronary Artery Disease; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Kidney Transplantation; Lipid Metabolism; Myocardial Revascularization; Nutritional Physiological Phenomena; Oxidative Stress; Parathyroid Hormone; Renal Insufficiency; Risk Factors; Vitamin D | 2003 |
Methyl group deficiency and guanidino production in uremia.
Topics: Animals; Arginine; Free Radicals; Guanidines; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Liver; Methionine; Mitochondria; Models, Biological; Models, Chemical; Oxygen; Succinates; Time Factors; Transaminases; Uremia | 2003 |
Traditional and emerging cardiovascular risk factors in end-stage renal disease.
Topics: Autonomic Nervous System Diseases; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Risk Factors; Sleep Apnea Syndromes | 2003 |
[Atherosclerosis and uremia: signifance of non-traditional risk factors].
Topics: Arginine; Arteriosclerosis; Homocysteine; Humans; Kidney Failure, Chronic; Oxidative Stress; Phosphates; Prognosis; Risk Factors; Uremia | 2003 |
Homocysteine metabolism in renal disease.
Topics: Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic | 2003 |
N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Contrast Media; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic | 2004 |
On-line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?
Topics: Dialysis Solutions; Dietary Proteins; Equipment Design; Glycation End Products, Advanced; Hemodiafiltration; Homocysteine; Humans; Kidney Failure, Chronic; Online Systems; Treatment Outcome | 2004 |
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking | 2004 |
The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians.
Topics: Body Composition; Cholesterol, LDL; Dietary Proteins; Dietetics; Erythropoietin; Homocysteine; Hospitalization; Humans; Inflammation; Kidney Failure, Chronic; Malnutrition; Nutrition Assessment; Nutritional Status; Quality of Life; Renal Dialysis | 2005 |
Homocysteine and methionine metabolism in renal failure.
Topics: Biomarkers; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Methionine; Methylation | 2005 |
Biomarkers in chronic kidney disease: utility and issues towards better understanding.
Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Chronic Disease; Disease Progression; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin T | 2005 |
Homocysteine-lowering treatment in coronary heart disease.
Topics: Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Vitamins | 2005 |
Reverse epidemiology: paradoxical observations in haemodialysis patients.
Topics: Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Glycation End Products, Advanced; Homocysteine; Humans; Hyperlipidemias; Hypertension, Renal; Hypotension; Kidney Failure, Chronic; Risk Factors | 2005 |
Chronic renal failure: a cardiovascular risk factor.
Topics: Albuminuria; Anemia; Calcinosis; Cardiovascular Diseases; Glomerular Filtration Rate; Homocysteine; Humans; Hypertrophy, Left Ventricular; Inflammation; Kidney; Kidney Failure, Chronic; Metabolic Syndrome; Oxidative Stress; Prevalence; Risk Factors; Sympathetic Nervous System; Uremia | 2005 |
Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Kidney Failure, Chronic; Malnutrition | 2006 |
[Homocysteine].
Topics: Animals; Arteriosclerosis; Biomarkers; Homocysteine; Humans; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Ischemia; Oxidative Stress; Polymorphism, Genetic; Risk Factors; Stroke; Thrombosis | 2006 |
Homocysteine lowering and cardiovascular disease risk: lost in translation.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors; Survival Rate; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
Topics: Arginine; Homocysteine; Humans; Kidney Failure, Chronic; Vascular Diseases | 2007 |
Mechanisms of homocysteine-induced glomerular injury and sclerosis.
Topics: Animals; Endoplasmic Reticulum; Homocysteine; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Methylation; Mitochondria; Models, Biological; Oxidative Stress; Oxygen; Reactive Oxygen Species; Sclerosis | 2008 |
[Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
Topics: Drug Therapy, Combination; Evidence-Based Medicine; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Renal Dialysis; Risk Factors | 1995 |
Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure?
Topics: Adult; Age Factors; Arteriosclerosis; Cystathionine beta-Synthase; Cysteine; Female; Folic Acid; Heterozygote; Homocysteine; Homocystinuria; Humans; Kidney Failure, Chronic; Male; Methionine; Methylation; Middle Aged; Renal Dialysis; Sex Factors | 1995 |
Membrane protein damage and methylation reactions in chronic renal failure.
Topics: Homocysteine; Humans; Kidney Failure, Chronic; Membrane Proteins; Methylation; Protein D-Aspartate-L-Isoaspartate Methyltransferase; Protein Methyltransferases; S-Adenosylhomocysteine; Substrate Specificity | 1996 |
Homocysteinemia and vascular disease in end-stage renal disease.
Topics: Arteriosclerosis; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Methionine; Middle Aged; Pyridoxine; Thrombosis; Vitamin B 12 | 1996 |
Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.
Topics: Arteriosclerosis; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male | 1997 |
Hyperhomocysteinemia: detection, risk assessment, and treatment.
Topics: Animals; Homocysteine; Humans; Kidney Failure, Chronic; Methionine; Risk Factors; Vascular Diseases | 1997 |
Role of homocysteine in age-related vascular and non-vascular diseases.
Topics: Aged; Aging; Alcoholism; Central Nervous System; Cerebrovascular Disorders; Cognition; Coronary Disease; Depression; Estrogens; Female; Folic Acid Deficiency; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Peripheral Vascular Diseases; Renal Replacement Therapy; Vascular Diseases; Vitamin B 12 Deficiency | 1997 |
Adverse effects of hyperhomocysteinemia and their management by folic acid.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Methylation; Risk Factors; Uremia | 1997 |
Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Pyridoxine; Renal Dialysis; Vitamin B 12 | 1998 |
Causes of coronary heart disease in patients on renal replacement therapy.
Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors | 1998 |
[Homocysteine as a nonlipid factor in the pathogenesis of atherosclerosis].
Topics: Aged; Animals; Arteriosclerosis; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis; Risk Factors | 1998 |
Interventions for other risk factors: tobacco use, physical inactivity, menopause, and homocysteine.
Topics: Cardiovascular Diseases; Comorbidity; Exercise; Female; Homocysteine; Humans; Kidney Failure, Chronic; Life Style; Male; Menopause; Prevalence; Risk Factors; Smoking; United States | 1998 |
Homocysteine and chronic renal failure.
Topics: Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors | 1998 |
Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?
Topics: Biomarkers; Coronary Artery Disease; Creatinine; Female; Graft Survival; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2000 |
Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients.
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetic Nephropathies; Diabetic Retinopathy; Endothelium, Vascular; Heart Transplantation; Hemodynamics; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Risk Factors | 1999 |
Homocysteine as a cardiovascular risk factor.
Topics: Cardiovascular Diseases; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors; Vitamins | 2000 |
Premature cardiovascular disease in chronic renal failure.
Topics: Acute-Phase Proteins; Anemia; Cardiovascular Diseases; Cause of Death; Cholesterol, HDL; Cholesterol, LDL; Homocysteine; Humans; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Research Design; Risk Factors | 2000 |
Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Oxidative Stress; Risk Factors; Uremia | 2000 |
Homocysteine and renal disease.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Case-Control Studies; Child; Endothelium, Vascular; Female; Folic Acid; Folic Acid Deficiency; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Life Tables; Male; Methionine; Peritoneal Dialysis; Prospective Studies; Pyridoxine; Renal Dialysis; Survival Analysis; Thrombophilia; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency | 2000 |
The careful correction of renal insufficiency abnormalities: early is good.
Topics: Anemia; Cardiovascular Diseases; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Nutrition Disorders; Risk Factors; Smoking | 2000 |
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Pyridoxine; Renal Dialysis; Risk Factors; Vitamin B 12 | 2000 |
C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD.
Topics: Arteriosclerosis; C-Reactive Protein; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Oxidative Stress; Prognosis; Troponin | 2000 |
Homocysteine metabolism in renal failure.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases | 2001 |
Cause and management of heart failure in patients with chronic renal disease.
Topics: Diabetes Complications; Heart Failure; Homocysteine; Humans; Hyperlipidemias; Hypertension; Kidney Failure, Chronic; Renal Dialysis; Risk Factors; Uremia | 2001 |
Hyperhomocysteinaemia and atherothrombosis.
Topics: Causality; Comorbidity; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Thrombosis | 2000 |
[Homocysteine--new risk factor for progression of atherosclerosis and its complications].
Topics: Arteriosclerosis; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors | 2001 |
Hyperhomocysteinemia in end-stage renal failure.
Topics: Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors | 2000 |
Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke.
Topics: Anemia, Pernicious; Brain Ischemia; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypothyroidism; Kidney Failure, Chronic; Male; Neoplasms; Risk Assessment; Risk Factors; Thrombosis | 2001 |
Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.
Topics: Animals; Arteriosclerosis; Chronic Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Dialysis; Stress, Mechanical; Vascular Diseases | 2001 |
Therapy of hyperhomocysteinemia in end-stage renal disease patients.
Topics: Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Replacement Therapy; Vitamin B 12; Vitamin B 6 | 2001 |
Editorial: Renal failure, homocysteine and the pharmacology of vitamin B12.
Topics: Homocysteine; Humans; Kidney Failure, Chronic; Vitamin B 12 | 2002 |
Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
Topics: Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic | 2002 |
Endothelial gene responses to homocysteine: relation to atherosclerosis.
Topics: Arteriosclerosis; Homocysteine; Humans; Kidney Failure, Chronic; Oligonucleotide Array Sequence Analysis | 2002 |
76 trial(s) available for homocysteine and Chronic Kidney Failure
Article | Year |
---|---|
Omega-3 in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis, Effects on Inflammatory Markers and Lipid Profile.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pilot Projects; Risk Factors | 2020 |
Effects of zinc supplement on plasma homocysteine level in end-stage renal disease patients: a double-blind randomized clinical trial.
Topics: Adult; Aged; Dietary Supplements; Double-Blind Method; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Zinc | 2013 |
Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Urea Nitrogen; Creatinine; Dietary Supplements; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Young Adult | 2013 |
Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes.
Topics: Adult; Aged; Aged, 80 and over; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Genotype; Hemodiafiltration; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Renal Dialysis; Vitamin B 12; Vitamins; Young Adult | 2015 |
Homocysteine levels after nitrous oxide anesthesia for living-related donor renal transplantation: a randomized, controlled, double-blind study.
Topics: Adult; Anesthesia, General; Anesthetics, Inhalation; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Longitudinal Studies; Male; Middle Aged; Nitrous Oxide; Postoperative Period; Prospective Studies | 2015 |
Effect of Vitamin B12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial.
Topics: Aged; Biomarkers; Dietary Supplements; Female; Hematocrit; Hemoglobins; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B Complex | 2016 |
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; China; Disease Progression; Double-Blind Method; Drug Combinations; Enalapril; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Vitamin B Complex | 2016 |
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Inflammation Mediators; Kidney Failure, Chronic; Lipoprotein(a); Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Receptor for Advanced Glycation End Products; Renal Dialysis | 2017 |
Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Mesna; Middle Aged; Pilot Projects; Renal Dialysis | 2009 |
Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial.
Topics: Administration, Oral; Adult; Cardiovascular Agents; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography, Doppler | 2009 |
Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Factor IX; Female; Fibrinogen; Homocysteine; Humans; Iran; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Phosphorus; Risk Factors; Soy Foods; Soybean Proteins; Thrombosis | 2009 |
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.
Topics: Age Factors; Aged; Cognition; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors; United States; United States Department of Veterans Affairs; Vitamin B Complex | 2009 |
B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Renal Dialysis; Risk; Treatment Failure; Treatment Outcome; Vitamin B Complex | 2010 |
Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis.
Topics: Administration, Oral; Aged; Arginine; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B 12; Vitamin B Complex | 2010 |
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.
Topics: Acetylcysteine; Administration, Oral; Adult; Antioxidants; Area Under Curve; Biomarkers; Delayed-Action Preparations; Down-Regulation; Female; Half-Life; Homocysteine; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Oxidative Stress; Prospective Studies; Treatment Outcome; United States | 2010 |
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Albuminuria; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Diabetes Complications; Female; Free Radical Scavengers; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Placebos; Proteins; Risk Factors; Sodium; Young Adult | 2010 |
The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
Topics: Aged; Cardiovascular Diseases; Diet Surveys; Dietary Fats; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Fatty Acids, Omega-3; Homocysteine; Humans; Kidney Failure, Chronic; Middle Aged; Phospholipids; Renal Dialysis; Risk Factors; Seafood; Self Report; Surveys and Questionnaires | 2010 |
Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis.
Topics: Aged; Aged, 80 and over; Cross-Over Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2011 |
Does hemodiafiltration improve the removal of homocysteine?
Topics: Adult; Aged; Aged, 80 and over; beta 2-Microglobulin; Cardiovascular Diseases; Cross-Sectional Studies; Female; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors | 2011 |
Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
Topics: Adolescent; Child; Child, Preschool; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Infant; Kidney Failure, Chronic; Male | 2002 |
Impairment of vascular responses to reactive hyperemia and nitric oxide in chronic renal failure.
Topics: Blood Pressure; Creatinine; Cysteine; Endothelium, Vascular; Female; Glutathione; Homocysteine; Humans; Hyperemia; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitric Oxide; Nitroglycerin; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2002 |
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Topics: Cysteine; Genotype; Glycine; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Threonine; Vitamin B 12 | 2003 |
Volume control and blood pressure management in patients undergoing quotidian hemodialysis.
Topics: Adult; Aged; Antihypertensive Agents; Appointments and Schedules; Blood Pressure; Extracellular Fluid; Female; Follow-Up Studies; Hemodialysis, Home; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Ontario; Prospective Studies; Treatment Outcome; Weight Gain | 2003 |
The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
Topics: Aged; Aged, 80 and over; Blood Proteins; Dialysis Solutions; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Polymethyl Methacrylate; Renal Dialysis; Serum Albumin | 2003 |
Acute effect of amino acid peritoneal dialysis solution on vascular function.
Topics: Adult; Amino Acids; Blood Flow Velocity; Blood Pressure; Cross-Over Studies; Endothelium, Vascular; Forearm; Glucose; Homocysteine; Humans; Hyperemia; Kidney Failure, Chronic; Middle Aged; Nitroglycerin; Peritoneal Dialysis; Plethysmography; Solutions; Vascular Diseases | 2003 |
Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
Topics: Adult; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intramuscular; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Vitamin B 12 | 2003 |
Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.
Topics: Acetylcysteine; Aged; Antioxidants; Blood Pressure; Cross-Over Studies; Endothelium, Vascular; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Vasodilation | 2004 |
Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.
Topics: Cardiovascular Diseases; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2004 |
Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
Topics: Administration, Oral; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Succimer; Vitamins | 2004 |
Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
Topics: Adolescent; Adult; Endothelin-1; Endothelium, Vascular; Female; Hand; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Raynaud Disease; Renal Dialysis; von Willebrand Factor | 2005 |
Dimethylglycine supplementation does not affect plasma homocysteine concentrations in pre-dialysis chronic renal failure patients.
Topics: Adult; Aged; Betaine; Homocysteine; Humans; Kidney Failure, Chronic; Methionine; Middle Aged; Renal Dialysis; Sarcosine | 2004 |
Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Topics: Aged; Aged, 80 and over; Creatine; Cross-Over Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Nutrition Assessment; Renal Dialysis; Vitamin B 12; Vitamin B 6 | 2004 |
Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
Topics: Adult; Amino Acids; Dialysis Solutions; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Function Tests; Male; Malnutrition; Middle Aged; Peritoneal Dialysis; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Taiwan; Treatment Outcome | 2005 |
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins.
Topics: Analysis of Variance; Diet, Protein-Restricted; Dietary Supplements; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Vitamin B Complex | 2005 |
Cobalamin dose regimen for maximum homocysteine reduction in end-stage renal disease.
Topics: Aged; Drug Administration Schedule; Homocysteine; Humans; Injections, Intravenous; Kidney Failure, Chronic; Middle Aged; Vitamin B 12 | 2005 |
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Over Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Male; Middle Aged; Prospective Studies; Renal Dialysis; Time Factors | 2005 |
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Topics: Aged; Aged, 80 and over; Cohort Studies; Diabetic Nephropathies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2005 |
Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease.
Topics: Cross-Over Studies; Female; Homocysteine; Humans; Hydroxocobalamin; Kidney Failure, Chronic; Male; Vitamin B 12 | 2005 |
Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Topics: Adult; Aged; Antioxidants; Arginine; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Female; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Solubility; Tunica Intima; Tunica Media; Ultrasonography; Vascular Cell Adhesion Molecule-1 | 2005 |
Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes.
Topics: Aged; Female; Folic Acid; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Renal Dialysis; Vitamin B 12; Vitamin B Complex | 2006 |
Homocysteine reduction rate in internal haemodiafiltration-a comparison with other mixed dialysis therapies.
Topics: Hemodiafiltration; Hemofiltration; Homocysteine; Humans; Kidney Failure, Chronic; Polymers; Renal Dialysis; Risk Factors; Sulfones; Time Factors; Treatment Outcome | 2006 |
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.
Topics: Coronary Disease; Death, Sudden, Cardiac; Disease-Free Survival; Echocardiography, Stress; Female; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Regression Analysis; Renal Dialysis; Risk Factors; Secondary Prevention | 2006 |
Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
Topics: Aged; Double-Blind Method; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Middle Aged; Renal Replacement Therapy; Vitamin B Complex | 2006 |
Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Proteins; Regression Analysis; Renal Dialysis; Survival Analysis; Vitamin B Complex | 2006 |
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease.
Topics: Ankle; Branchial Region; Carnitine; Double-Blind Method; Endothelin-1; Homocysteine; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Peripheral Vascular Diseases; Placebos; Renal Dialysis | 2006 |
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Recurrence; Vitamins | 2006 |
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
Topics: Atherosclerosis; Carotid Arteries; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Ultrasonography; Vitamin B 12; Vitamin B 6 | 2006 |
Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease.
Topics: Acetylcysteine; Adult; Aged; Blood Pressure; Blood Proteins; Diabetic Nephropathies; Drug Administration Schedule; Female; Heart Rate; Hematocrit; Homocysteine; Humans; Hypertension; Infusions, Intravenous; Kidney Calculi; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Urticaria | 2006 |
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxid
Topics: Administration, Oral; Carotid Artery, Common; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Pravastatin; Pyridoxine; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Ultrasonography; Vitamin E; Vitamins | 2007 |
Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.
Topics: Aged; Diabetic Nephropathies; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Tetrahydrofolates; Ultrasonography; Uremia; Vasodilation | 2007 |
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Topics: Aged; Cause of Death; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Pyridoxine; Renal Insufficiency, Chronic; Vascular Diseases; Vitamin B 12; Vitamin B Complex | 2007 |
Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
Topics: Aged; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Vitamin B 12; Vitamin B 6 | 2008 |
Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
Topics: Adult; Carotid Arteries; DNA Methylation; Double-Blind Method; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Leukocytes; Male; Middle Aged; Pravastatin; Tunica Intima; Vitamin B Complex; Vitamin E | 2008 |
Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
Topics: Aged; Corn Oil; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Nonprescription Drugs; Prospective Studies; Renal Dialysis; Texas; Time Factors; Treatment Outcome; Up-Regulation | 2008 |
Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
Topics: Aged; Double-Blind Method; Drug Administration Schedule; Female; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intravenous; Kidney Failure, Chronic; Male; Mesna; Renal Dialysis; Treatment Outcome | 2008 |
Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Creatinine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Male; Middle Aged; Retrospective Studies; Risk Factors | 1994 |
Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Arteriosclerosis; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1996 |
Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Creatinine; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyridoxine | 1996 |
Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients.
Topics: Aged; Arteriosclerosis; Female; Homocysteine; Humans; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Prospective Studies; Regression Analysis; Renal Dialysis; Uremia | 1997 |
Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
Topics: Adult; Betaine; Fasting; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methionine; Methylation; Middle Aged; Renal Dialysis; Time Factors; Treatment Outcome | 1999 |
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy.
Topics: Age Factors; Analysis of Variance; Biomarkers; Blood Pressure; Brachial Artery; Carotid Artery, Common; Compliance; Endothelins; Homocysteine; Humans; Kidney Failure, Chronic; Pyridoxine; Regression Analysis; Renal Dialysis; Vasodilation; Vitamin B 12; von Willebrand Factor | 2000 |
A tale of two homocysteines--and two hemodialysis units.
Topics: Aged; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Cystine; Female; Fluorometry; Folic Acid; Hematinics; Hemodialysis Units, Hospital; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Regression Analysis; Vitamin B 12 | 2000 |
A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease.
Topics: Adult; Aged; Arteriosclerosis; Double-Blind Method; Female; Folic Acid; Hemorheology; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors | 2000 |
Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Topics: Aged; Cohort Studies; Female; Folic Acid; Follow-Up Studies; Genotype; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Renal Dialysis; Solubility; Vitamin B Complex | 2000 |
Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
Topics: Aged; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Erythrocytes; Female; Folic Acid; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitrites; Placebos; Prospective Studies; Renal Dialysis; Ultrasonography; Vasodilation; von Willebrand Factor | 2000 |
Cardiac troponin T predicts mortality in patients with end-stage renal disease.
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; Survival Rate; Troponin T | 2000 |
Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Renal Dialysis; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor | 2000 |
Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.
Topics: Adult; Arteriosclerosis; Cholesterol; Creatinine; Drug Therapy, Combination; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Lipoprotein(a); Male; Pyridoxine; Renal Dialysis; Risk Factors; Triglycerides; Urea; Uric Acid; Vitamin B 12; Vitamin B Complex | 2001 |
Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
Topics: Cysteine; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Subcutaneous; Kidney Failure, Chronic; Methylmalonic Acid; Renal Dialysis; Vitamin B 12 | 2001 |
Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
Topics: Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxine; Renal Dialysis; Vitamin B 12 | 2001 |
Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
Topics: Female; Folic Acid; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxine; Regression Analysis; Renal Dialysis; Vitamin B 12; Vitamin B Complex | 2001 |
Plasma homocysteine concentration in children with chronic renal failure.
Topics: Adolescent; Aging; Child; Child, Preschool; Diet; Female; Folic Acid Deficiency; Genotype; Homocysteine; Humans; Infant; Kidney Failure, Chronic; Kidney Function Tests; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Renal Dialysis; Vitamin B 12 | 2001 |
Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.
Topics: Aged; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxal Phosphate; Vitamin B 6 | 2002 |
Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?
Topics: Administration, Oral; Adolescent; Child; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Nitroglycerin; Oxidative Stress; Vasodilation; Vasodilator Agents; Vasomotor System | 2002 |
[Levels of carnitine and homocysteine in plasma of long-term hemodialysis patients with chronic renal failure].
Topics: Adult; Carnitine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2001 |
Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Topics: Aged; Female; Folic Acid; Homocysteine; Humans; Hydroxocobalamin; Hyperhomocysteinemia; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Methylmalonic Acid; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome; Vitamin B 12 | 2002 |
243 other study(ies) available for homocysteine and Chronic Kidney Failure
Article | Year |
---|---|
Dietary intake, clinical-nutritional status, and homocysteine in hemodialysis subjects: the mediating role of inflammation (NUGE-HD study).
Topics: Aged; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus; Diet; Fatty Acids; Female; Folic Acid; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Renal Dialysis; Vitamin B Complex | 2020 |
Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients.
Topics: Adult; Aged; Biomarkers; Catalase; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erythrocytes; Female; Glutathione Transferase; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uremia | 2014 |
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.
Topics: Aged; Aspirin; Biomarkers; Chi-Square Distribution; Diabetes Complications; Female; Fibrinolytic Agents; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors; Thrombosis; Up-Regulation | 2013 |
[Evaluation of the interdependence between homocystein and folic acid levels in patients after kidney transplantation during a 2 year observation period].
Topics: Adolescent; Adult; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Young Adult | 2013 |
Omega-3 and serum homocysteine level in hemodialysis patients.
Topics: Dietary Supplements; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male | 2013 |
Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Restless Legs Syndrome; Sleep; Uremia | 2013 |
[The degree of chronic renal failure is associated with the rate of pro-inflammatory cytokines, hyperhomocysteinemia and with oxidative stress].
Topics: Adult; Aged; Biomarkers; Cytokines; Female; Homocysteine; Humans; Interleukin-1beta; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Predictive Value of Tests; Sensitivity and Specificity; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2014 |
Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
Topics: Adult; Biomarkers; Blood Urea Nitrogen; Chi-Square Distribution; Creatinine; Cross-Sectional Studies; Cyclosporine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Iran; Kidney Failure, Chronic; Kidney Transplantation; Linear Models; Male; Middle Aged; Multivariate Analysis; Prevalence; Risk Factors; Time Factors; Vitamin B 12 | 2014 |
Comparison of a new microbiological assay with a standard high-performance liquid chromatographic method for determination of vitamin B6 in serum.
Topics: Adolescent; Adult; Biosensing Techniques; Chromatography, High Pressure Liquid; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Reagent Kits, Diagnostic; Regression Analysis; Reproducibility of Results; Saccharomyces cerevisiae; Vitamin B 6; Young Adult | 2014 |
Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2014 |
Association of clearance of middle- and large-molecular-weight substance with arterial stiffness and left ventricular mass in children receiving renal replacement therapy.
Topics: Adolescent; beta 2-Microglobulin; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Child; Child, Preschool; Female; Heart Ventricles; Homocysteine; Humans; Kidney Failure, Chronic; Male; Molecular Weight; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors; Time Factors; Toxins, Biological; Vascular Stiffness | 2017 |
Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Calcium; Case-Control Studies; Creatinine; Disease Progression; Early Diagnosis; Egypt; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Renal Dialysis; Serum Albumin | 2016 |
Serum albumin and von Willebrand factor: possible markers for early detection of vascular damage in children undergoing peritoneal dialysis.
Topics: Adolescent; Apolipoproteins A; Apolipoproteins B; Blood Pressure; C-Reactive Protein; Carotid Intima-Media Thickness; Child; Cross-Sectional Studies; Female; Hemoglobins; Homocysteine; Humans; Kidney Failure, Chronic; Male; Parathyroid Hormone; Peritoneal Dialysis; Regression Analysis; Risk Factors; Serum Albumin; Vascular Diseases; von Willebrand Factor | 2016 |
Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Endocarditis; Female; Heart Valve Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Young Adult | 2016 |
Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peroxidase; Renal Dialysis; Risk Factors | 2008 |
Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
Topics: Adult; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Renal Dialysis; Vitamins | 2008 |
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Confidence Intervals; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Ohio; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate | 2008 |
Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Topics: C-Reactive Protein; Cardiovascular Diseases; Creatinine; Female; Follow-Up Studies; Homocysteine; Humans; Inflammation; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Malnutrition; Middle Aged; Nutritional Status; Prospective Studies; Renal Dialysis; Risk Factors; Serum Albumin; Treatment Outcome | 2008 |
Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction).
Topics: Adult; Aged; Cardiovascular Diseases; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged | 2008 |
Validation of a composite scoring scheme in the diagnosis of folate deficiency in a pediatric and adolescent dialysis cohort.
Topics: Adolescent; Analysis of Variance; Cohort Studies; Diagnosis, Differential; Erythrocytes; Erythropoietin; Female; Folic Acid; Folic Acid Deficiency; Hemoglobins; Homocysteine; Humans; Iron; Kidney Failure, Chronic; Male; Predictive Value of Tests; Recombinant Proteins; Renal Dialysis; Sensitivity and Specificity | 2008 |
[The importance of homocysteinemia measurement in chronic renal failure].
Topics: Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged | 2007 |
Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats.
Topics: Animals; Disease Models, Animal; Extracellular Matrix; Folic Acid; Homocysteine; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Glomerulus; Matrix Metalloproteinases; NADPH Oxidases; Oxidative Stress; Proto-Oncogene Proteins c-vav; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; RNA; Sclerosis; Superoxides; Tissue Inhibitor of Metalloproteinase-1; Transfection | 2009 |
Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Risk Factors; Troponin T; Young Adult | 2008 |
Predictors for cardiovascular morbidity and overall mortality in Tunisian ESRD patients: a six year prospective study.
Topics: Adolescent; Adult; Aged; Albumins; Black People; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Female; Hemoglobins; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Proportional Hazards Models; Prospective Studies; Tunisia; Young Adult | 2009 |
Metabolic abnormalities are present in adults with elevated serum cystatin C.
Topics: Adult; Age Factors; C-Reactive Protein; Cystatin C; Female; Fibrinogen; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Male; Nutrition Surveys; Phosphorus; Prevalence; Reference Values; United States | 2009 |
Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.
Topics: Animals; Antioxidants; Apoptosis; Cystathionine beta-Synthase; Desmin; Disease Models, Animal; Glutathione; Glutathione Disulfide; Homocysteine; Hydrogen Sulfide; Hyperhomocysteinemia; Kidney; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; Oxidative Stress; Proteinuria; Sulfides; Superoxides | 2009 |
Role of thrombotic risk factors in end-stage renal disease.
Topics: 3' Untranslated Regions; Adult; Alleles; Amino Acid Substitution; Factor V; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Point Mutation; Prothrombin; Risk Factors; Thrombophilia; Vitamin B 12; Young Adult | 2010 |
Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Cardiovascular Diseases; Cross-Sectional Studies; Eating; Female; Folic Acid; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lipoprotein(a); Lovastatin; Male; Middle Aged; Pyrroles; Renal Dialysis; Risk Factors; Vitamin B 6; Vitamin B Complex; Young Adult | 2009 |
The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Pulse; Risk Factors; Young Adult | 2010 |
Effect of renal transplantation on coronary artery calcification in hemodialysis patients.
Topics: Adult; Calcinosis; Cholesterol; Coronary Artery Disease; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Triglycerides; Ultrasonography; Young Adult | 2009 |
Elevated homocysteine is a predictor of all-cause mortality in a prospective cohort of renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Female; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Period; Predictive Value of Tests; Risk Assessment; Survival Analysis | 2010 |
Observational study on markers of cardiovascular risk in renal patient: conventional hemodialysis vs. haemofiltration online.
Topics: Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Female; Folic Acid; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Obesity; Online Systems; Renal Dialysis; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B 12 | 2009 |
Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis.
Topics: Adult; Ascorbic Acid; C-Reactive Protein; Cross-Sectional Studies; Cysteine; Dietary Proteins; Energy Intake; Erythrocytes; Female; Glutathione; Glutathione Reductase; Hemodialysis, Home; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Renal Dialysis; Riboflavin; Vitamins | 2010 |
Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Renal Dialysis; Spectrophotometry; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2009 |
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Assessment; Risk Factors; Serum Albumin; Uremia | 2010 |
Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.
Topics: Adolescent; Adult; Aged; Anemia; Erythropoietin; Female; Ferritins; Hemoglobins; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Renal Dialysis; Risk Factors; Transferrin; Young Adult | 2010 |
Relationship between insulin resistance and inflamation markers in hemodialysis patients.
Topics: Albumins; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism; Male; Renal Dialysis; Risk Factors; Urea; Uric Acid | 2010 |
Antibodies against N-homocysteinylated proteins and their determinants in patients on long-term hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Female; Hemoglobins; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Renal Dialysis; Serum Albumin; Young Adult | 2010 |
Hyperhomocysteinemia and cardiovascular risks in hemodialysis patients.
Topics: Adult; Aortic Valve Insufficiency; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Echocardiography, Doppler; Echocardiography, Doppler, Color; Female; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Renal Dialysis; Risk Assessment; Risk Factors; Stroke Volume; Up-Regulation; Ventricular Function, Left | 2010 |
Serum folate and homocysteine levels are associated with colon tumorigenesis in end-stage renal disease patients.
Topics: Adult; Aged; Aged, 80 and over; Colon; Colonic Neoplasms; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Renal Dialysis; Risk Factors; Serum | 2011 |
Total, free, and protein-bound thiols in plasma of peritoneal dialysis and predialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Female; Glutathione; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Statistics, Nonparametric; Sulfhydryl Compounds | 2011 |
The presence of PAI-1 4G/5G and ACE DD genotypes increases the risk of early-stage AVF thrombosis in hemodialysis patients.
Topics: Adult; Arteriovenous Shunt, Surgical; Blood Coagulation Factors; Case-Control Studies; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Renal Dialysis; Thrombosis | 2011 |
What is the meaning of homocysteine in patients on dialysis?
Topics: Adult; Aged; Biomarkers; Brazil; C-Reactive Protein; Creatine Kinase; Creatinine; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Kidney Failure, Chronic; Linear Models; Lipids; Male; Malnutrition; Middle Aged; Peritoneal Dialysis; Prevalence; Renal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha; Vitamin B 12 | 2011 |
Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Cholesterol, HDL; Creatine; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Superoxides | 2011 |
Lipid profiles and oxidative stress parameters in male and female hemodialysis patients.
Topics: Aged; Atherosclerosis; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Risk Assessment; Risk Factors; Triglycerides; Vitamin B 12 | 2011 |
Persistent homocysteine metabolism abnormality accelerates cardiovascular disease in hemodialyzed patients--the Nishinomiya Study.
Topics: Body Mass Index; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Renal Dialysis; Vitamin B 12 | 2012 |
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Pressure; Body Mass Index; Chromatography, Liquid; Cohort Studies; Creatinine; Female; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Radioisotope Dilution Technique; Reference Values; Tandem Mass Spectrometry; United States | 2011 |
Erythrocyte glutathione transferase: a potential new biomarker in chronic kidney diseases which correlates with plasma homocysteine.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Erythrocytes; Female; Glutathione Transferase; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Young Adult | 2012 |
Therapy of hyperhomocysteinemia in hemodialysis patients: effects of folates and N-acetylcysteine.
Topics: Acetylcysteine; Aged; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2012 |
Association factors of target organ damage: analysis of 17,682 elderly hypertensive patients in China.
Topics: Aged; Aged, 80 and over; Aortic Diseases; Cerebrovascular Disorders; China; Cholesterol, LDL; Coronary Artery Disease; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies | 2011 |
Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
Topics: Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Case-Control Studies; Chi-Square Distribution; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Logistic Models; Male; Middle Aged; Renal Dialysis; Statistics, Nonparametric | 2012 |
Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Pressure Determination; Cohort Studies; Echocardiography, Doppler; Female; Glomerular Filtration Rate; Heart Failure, Systolic; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome; Urination; Urine | 2013 |
Homocysteine and cystatin C level changes in haemodialysed patients and connection with cerebro- and cardiovascular complications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Cystatin C; Cystatins; Diabetes Mellitus, Type 1; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stroke | 2001 |
Plasma homocysteine concentration changes after renal transplantation in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Serum Albumin; Vitamin B 12 | 2002 |
[Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Topics: Adult; Age Factors; Aged; Female; Folic Acid; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Renal Dialysis; Time Factors; Vitamin B 12 | 2002 |
The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prevalence; Renal Dialysis; Risk Factors | 2002 |
Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients.
Topics: Adolescent; Adult; Age Factors; Disease Progression; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Single Nucleotide; Renal Dialysis; Risk Factors | 2002 |
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Topics: Adult; Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cysteine; Deficiency Diseases; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Nutrition Assessment; Nutrition Disorders; Nutritional Status; Prevalence; Protein-Energy Malnutrition; Renal Dialysis; Serum Albumin | 2002 |
Homocysteine in chronic renal failure in relation to renal anemia and to oxidative stress parameters 4-hydroxynonenal and malondialdehyde.
Topics: Aldehydes; Anemia; Cardiovascular Diseases; Female; Hemoglobins; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Dialysis; Risk Factors | 2002 |
The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis.
Topics: Adult; Aged; Body Mass Index; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B 6 | 2001 |
Comparison of two micronutrient supplements in children with chronic renal failure.
Topics: Adolescent; Child; Child Nutritional Physiological Phenomena; Child, Preschool; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Infant; Kidney Failure, Chronic; Male; Micronutrients; Minerals; Nutritional Status; Odorants; Peritoneal Dialysis; Pilot Projects; Renal Dialysis; Surveys and Questionnaires; Taste; Trace Elements; Vitamins | 2002 |
Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease.
Topics: Analysis of Variance; Cysteine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Sulfates; Urea | 2002 |
Relationship of renal function to homocysteine and lipoprotein(a) levels: the frequency of the combination of both risk factors in chronic renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Chromium Radioisotopes; Diabetes Complications; Diabetes Mellitus; Edetic Acid; Female; Glomerular Filtration Rate; Glomerulonephritis; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Lipoprotein(a); Male; Metabolic Clearance Rate; Middle Aged; Polycystic Kidney Diseases; Risk Factors | 2002 |
[Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].
Topics: Adult; Aged; Alleles; DNA; DNA Mutational Analysis; Gene Frequency; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Renal Dialysis | 2002 |
[The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure].
Topics: Adult; Arteriosclerosis; Carotid Arteries; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Regression Analysis | 2002 |
Amino acid loss with polyethersulfone.
Topics: Aged; Amino Acids; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Nutrition Disorders; Polymers; Renal Dialysis; Sulfones | 2003 |
Reduction of total homocysteine levels by oral folic acid fails to improve endothelial function in children with chronic renal failure.
Topics: Administration, Oral; Arginine; Child; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Vasodilation | 2003 |
Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy.
Topics: Creatinine; Endothelium, Vascular; Female; Hemoglobins; Homocysteine; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Leucovorin; Longitudinal Studies; Male; Malondialdehyde; Middle Aged; Mutation; Renal Dialysis; Serum Albumin | 2002 |
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors | 2003 |
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
Topics: Arteriovenous Shunt, Surgical; Cross-Sectional Studies; Cytosine; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Renal Dialysis; Risk Factors; Thrombosis; Thymine | 2003 |
Free cysteine is increased in plasma from hemodialysis patients.
Topics: Acids; Adult; Cysteine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Solubility; Sulfhydryl Compounds | 2003 |
Homocysteine, folate, vitamin B12 levels, and C677T MTHFR mutation in children with renal failure.
Topics: Adolescent; Child; Child, Preschool; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Predictive Value of Tests; Prevalence; Regression Analysis; Vitamin B 12 | 2003 |
[Some aspects of homocysteine metabolism in hemodialysis patients].
Topics: Adult; Aged; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Renal Dialysis | 2002 |
Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.
Topics: Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Endothelium, Vascular; Homocysteine; Humans; Inflammation Mediators; Kidney; Kidney Failure, Chronic; Risk Factors | 2003 |
Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.
Topics: Creatinine; Female; Hemoglobins; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Risk Factors; Vascular Diseases | 2003 |
Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients.
Topics: Adult; Aged; Antigens, Surface; Carboxypeptidases; Carrier Proteins; Erythrocytes; Female; Folate Receptors, GPI-Anchored; Folic Acid; Genotype; Glutamate Carboxypeptidase II; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Receptors, Cell Surface; Renal Dialysis | 2003 |
[Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors | 2002 |
Hyperhomocysteinemia and oxidative stress during dialysis treatment.
Topics: Adult; Aged; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors; Vascular Diseases | 2003 |
Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
Topics: Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Risk; Thrombosis | 2003 |
Variations in the lipid profile of patients with chronic renal failure, treated with folic acid.
Topics: Arteriosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Erythrocytes; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intravenous; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Renal Dialysis; Triglycerides | 2003 |
C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Chronic Disease; Cross-Sectional Studies; Cytokines; Female; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Japan; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Risk Factors; Sex Factors; Ultrasonography | 2003 |
Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients.
Topics: Adult; Aged; Biological Availability; Cross-Sectional Studies; Cytosine; Female; Genotype; Guanine; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Osmolar Concentration; Transcobalamins; Vitamin B 12 | 2003 |
Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Blood Pressure; Blood Proteins; Disease Models, Animal; Homocysteine; Kidney Failure, Chronic; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nephrectomy; Uremia | 2003 |
Inverse association between homocysteine and vascular endothelial growth factor receptor 2 serum levels in hemodialyzed and kidney transplanted patients.
Topics: Adult; Aged; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Renal Dialysis | 2003 |
[Alteration of homocysteine before and after hemodialysis in chronic hemodialysis patients].
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2003 |
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Heptanoic Acids; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Lipid Metabolism; Lipids; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pyrroles; Renal Dialysis; Risk Factors | 2003 |
Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
Topics: Ascorbic Acid; Dietary Supplements; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Proteins; Renal Dialysis; Vitamin B 12; Vitamin E | 2003 |
Renal disease, homocysteine, and cardiovascular complications.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Risk Factors | 2004 |
Low initial vitamin B12 levels in Helicobacter pylori--positive patients on chronic hemodialysis.
Topics: Anemia, Macrocytic; Female; Folic Acid; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Renal Dialysis; Retrospective Studies; Vitamin B 12; Vitamin B 12 Deficiency | 2004 |
Heme oxygenase 1 expression in young uremic patients on hemodialysis.
Topics: Adult; Bilirubin; Ceruloplasmin; Down-Regulation; Female; Glutathione; Glutathione Disulfide; Heme Oxygenase (Decyclizing); Hemoglobins; Homocysteine; Humans; Kidney Failure, Chronic; Male; Oxidative Stress; Renal Dialysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Uremia | 2004 |
[Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
Topics: Adult; Aged; Arteriosclerosis; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Female; Fluorescence Polarization Immunoassay; Glutathione Peroxidase; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Spectrophotometry; Tumor Necrosis Factor-alpha | 2004 |
Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients.
Topics: Adult; Analysis of Variance; Base Sequence; Cross-Sectional Studies; Female; Ferredoxin-NADP Reductase; Folic Acid; Gene Expression; Graft Rejection; Graft Survival; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Mutation; Polymerase Chain Reaction; Prognosis; Vitamin B 12 | 2004 |
Selective adsorption of homocysteine using an HFR-ON LINE technique.
Topics: Adsorption; Adult; Equipment Design; Equipment Safety; Female; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Probability; Sampling Studies; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome | 2004 |
Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Cyclic GMP; Diastole; Endothelium, Vascular; Female; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitrites; Regional Blood Flow; Renal Circulation; Renal Dialysis; Risk Factors; Statistics as Topic; Systole; Time Factors; Treatment Outcome; Vascular Diseases; Vasodilation | 2004 |
Plasma homocysteine levels in living kidney donors before and after uninephrectomy.
Topics: Adult; Creatinine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Middle Aged; Nephrectomy | 2004 |
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Case-Control Studies; Chronic Disease; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors; Thrombosis | 2004 |
Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.
Topics: Adult; Aged; Arteriosclerosis; Carotid Artery Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Risk Factors | 2004 |
Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
Topics: Adult; Aged; Case-Control Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Sulfur | 2004 |
Classical and "non-classical" cardiovascular risk factors in Tunisian patients with end stage renal disease: prevalence and association with cardiovascular events.
Topics: Adult; Age Factors; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Risk Factors; Tunisia | 2004 |
Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
Topics: Aged; Aged, 80 and over; Cystathionine; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylmalonic Acid; Middle Aged; Renal Dialysis; Vitamin B 12; Vitamin B 6 | 2005 |
Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
Topics: Adult; Fasting; Female; Follow-Up Studies; Graft Survival; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Survival Analysis; Transplantation, Homologous | 2005 |
Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients.
Topics: Age Distribution; Aged; Analysis of Variance; Arteriovenous Shunt, Surgical; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Probability; Renal Dialysis; Retrospective Studies; Risk Assessment; Sex Distribution; Statistics, Nonparametric; Venous Thrombosis | 2004 |
Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Topics: Administration, Oral; Adult; Aged; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kinetics; Male; Methionine; Methylation; Middle Aged; Renal Dialysis | 2005 |
Cellular uptake of vitamin B12 in patients with chronic renal failure.
Topics: Adult; Aged; Cells, Cultured; Cystathionine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Leukocytes, Mononuclear; Male; Methylmalonic Acid; Middle Aged; Vitamin B 12 | 2005 |
Cardiovascular risk markers in hemodialysis patients.
Topics: Aged; Cardiovascular Diseases; Creatine Kinase; Creatine Kinase, MB Form; Female; Homocysteine; Humans; Isoenzymes; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Renal Dialysis; Risk Factors; Troponin I; Uremia | 2004 |
The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors | 2004 |
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Topics: Aged; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Transcobalamins; Vitamin B 12; Vitamin B 6 | 2005 |
Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cholesterol, LDL; Comorbidity; Female; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Hong Kong; Humans; Hypertrophy, Left Ventricular; Kidney; Kidney Failure, Chronic; Life Tables; Lipids; Male; Middle Aged; Mortality; Peritoneal Dialysis, Continuous Ambulatory; Proportional Hazards Models; Prospective Studies; Risk; Serum Albumin; Solubility; Survival Analysis; Treatment Outcome; Ultrasonography; Vascular Cell Adhesion Molecule-1 | 2005 |
Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism.
Topics: Adult; Aged; Anti-Inflammatory Agents; Atherosclerosis; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Fibrinolytic Agents; Heart Rate; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoproteins, VLDL; Male; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2005 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular System; Cohort Studies; Dialysis; Disease Progression; Enzyme Inhibitors; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Middle Aged; Models, Statistical; Models, Theoretical; Proportional Hazards Models; Proteinuria; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?
Topics: Albumins; Anemia; Clinical Trials as Topic; Dialysis Solutions; Glycosylation; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Kidney Failure, Chronic; Membranes, Artificial; Molecular Weight; Oxygen; Proteins; Renal Dialysis; Time Factors | 2005 |
Hyperhomocysteinaemia and aortic calcification are associated with fractures in patients on haemodialysis.
Topics: Aged; Calcinosis; Cross-Sectional Studies; Female; Fractures, Bone; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spinal Fractures; Vascular Diseases | 2005 |
Better stability of total homocysteine measurement with sodium fluoride than with EDTA.
Topics: Blood Preservation; Edetic Acid; Homocysteine; Humans; Immunoassay; Kidney Failure, Chronic; Reproducibility of Results; Sodium Fluoride | 2005 |
Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Diet, Vegetarian; Female; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Regression Analysis; Risk Factors; Serum Albumin; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamins | 2005 |
Correlation of plasma homocysteine level with arterial stiffness and pulse pressure in hemodialysis patients.
Topics: Adult; Aged; Atherosclerosis; Blood Pressure; Brachial Artery; Female; Ferritins; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors | 2005 |
Inhibitory effect of PPAR-gamma activator on IL-6 and mPGES protein expression in PBMC induced by homocysteine.
Topics: Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Homocysteine; Humans; Interleukin-6; Intramolecular Oxidoreductases; Kidney Failure, Chronic; Leukocytes, Mononuclear; Microsomes; PPAR gamma; Prostaglandin-E Synthases; Renal Dialysis; Rosiglitazone; Thiazolidinediones; Troglitazone | 2005 |
Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study.
Topics: Adult; Cause of Death; Double-Blind Method; Folic Acid; Homocysteine; Hospitals, Veterans; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Middle Aged; Multicenter Studies as Topic; Patient Selection; Prospective Studies; Pyridoxine; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Treatment Outcome; Vitamin B 12 | 2004 |
Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
Topics: Alleles; Case-Control Studies; Cross-Sectional Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Predictive Value of Tests | 2005 |
Elevated homocysteine levels in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Statistics, Nonparametric; Vitamin B 12 | 2005 |
Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Chronic Disease; Cysteine; Dipeptides; Female; Folic Acid; Glutathione; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Oxidation-Reduction; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Vitamin B 12 | 2006 |
Homocysteine and risk in end-stage renal disease: a matter of context.
Topics: Blood Pressure; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Kidney Failure, Chronic; Malnutrition; Risk Factors | 2006 |
[Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Topics: Atherosclerosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylenetetrahydrofolate Reductase (NADPH2); Renal Dialysis; Risk Factors; Thrombosis; Vitamin B 12; Vitamin B Complex | 2005 |
Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Topics: Anthropometry; Case-Control Studies; Creatinine; Cross-Sectional Studies; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Function Tests; Linear Models; Male; Middle Aged; Nutrition Assessment; Nutritional Status; Prevalence; Vitamin B 12 | 2006 |
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
Topics: Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Function Tests; Male; Prognosis; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vitamin B 6 | 2006 |
Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Platelet Aggregation; Renal Dialysis; Thromboplastin; Vitamin B 12; Vitamin B 6 | 2006 |
Homocysteine targeting of plasma proteins in hemodialysis patients.
Topics: Blood Proteins; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Protein Processing, Post-Translational; Renal Dialysis | 2006 |
Relationship between hyperhomocysteinemia and atherosclerosis in chronic hemodialysis patients.
Topics: Adult; Aged; Atherosclerosis; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B Complex | 2005 |
Testing the homocysteine hypothesis in end-stage renal disease: Problems and a possible solution.
Topics: Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Vitamin B 12 | 2006 |
Fuzzy role of hyperhomocysteinemia in hemodialysis patients' mortality.
Topics: Adult; Aged; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2006 |
The challenge of the unacceptable high mortality in end-stage kidney disease: is folic acid the answer?
Topics: Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic | 2006 |
Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Atherosclerosis; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Cross-Sectional Studies; Female; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Malnutrition; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Statistics, Nonparametric; Syndrome; Treatment Outcome | 2006 |
Platelet activity and serum homocysteine levels in patients with end-stage renal failure with regard to dialysis modality.
Topics: Aged; Analysis of Variance; Female; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; P-Selectin; Peritoneal Dialysis, Continuous Ambulatory; Platelet Activation; Renal Dialysis; Statistics, Nonparametric | 2006 |
[Characteristics of hyperhomocysteinemia in dialysis patients].
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Dyslipidemias; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors | 2006 |
[The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
Topics: Aged; Dose-Response Relationship, Drug; Female; Folic Acid; Hematologic Tests; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Reference Values; Renal Dialysis; Thrombosis; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2004 |
Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sulfhydryl Compounds | 2006 |
[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Polymers; Renal Dialysis; Sulfones; Vitamin B Complex | 2006 |
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Topics: Adult; Aged; C-Reactive Protein; Female; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Models, Statistical; Nutritional Sciences; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2007 |
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Disease Progression; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Polymorphism, Single Nucleotide; Time Factors | 2007 |
Letter by Undas and Jakubowski regarding article, "Relationship between homocysteine and mortality in chronic kidney disease".
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic | 2006 |
Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Comorbidity; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Proportional Hazards Models; Regression Analysis; Renal Dialysis; Risk Factors | 2006 |
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
Topics: Adult; Arginine; Atherosclerosis; Biomarkers; Carotid Artery, Common; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Organophosphates; Prognosis; Prospective Studies; Renal Dialysis; Severity of Illness Index; Time Factors; Tunica Intima; Ultrasonography | 2006 |
The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Mesna; Middle Aged; Pilot Projects; Renal Dialysis | 2007 |
Homocysteine and reverse epidemiology.
Topics: Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Renal Dialysis; Risk Factors; Wasting Syndrome | 2007 |
[Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease].
Topics: Adult; Annexins; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Disease Progression; Endothelium, Vascular; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Risk Factors; Tunica Intima; Ultrasonography, Doppler | 2007 |
Folic acid for stroke prevention.
Topics: Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Research Design; Risk; Stroke; Vitamin B Complex | 2007 |
Acute effects of haemodialysis on biochemical modulators of endothelial function.
Topics: Arginine; Blood Pressure; C-Reactive Protein; Endothelium, Vascular; Female; Folic Acid; Heart Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Renal Dialysis; Vasodilation | 2007 |
Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery.
Topics: Acute-Phase Proteins; Adolescent; Adult; Atherosclerosis; Biomarkers; Carotid Artery, Common; Carotid Artery, Internal; Child; Creatinine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Male; Prognosis; Risk Factors; Time Factors; Tunica Intima; Ultrasonography | 2007 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
Homocysteine lowering and severe kidney disease.
Topics: Dietary Supplements; Homocysteine; Humans; Kidney Failure, Chronic; Vitamins | 2008 |
Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cysteine; Dialysis; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Oxidation-Reduction; Statistics, Nonparametric; Sulfhydryl Compounds; Vitamin B Complex | 2008 |
Positive association between plasma homocysteine level and chronic kidney disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Sex Factors | 2008 |
Interleukin-6 is a better predictor of mortality as compared to C-reactive protein, homocysteine, pentosidine and advanced oxidation protein products in hemodialysis patients.
Topics: Adult; Arginine; C-Reactive Protein; Female; Glycation End Products, Advanced; Homocysteine; Humans; Interleukin-6; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Oxidation-Reduction; Prognosis; Proteins; Renal Dialysis; Survival Rate | 2008 |
Inflammation, homocysteine and carotid intima-media thickness.
Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Risk Factors; Tunica Intima; Tunica Media | 2008 |
Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
Topics: Aged; Aged, 80 and over; Case-Control Studies; DNA Damage; Female; Folic Acid; Genome, Human; Homocysteine; Humans; Kidney Failure, Chronic; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Neoplasms; Prospective Studies; Renal Dialysis; Vitamin B 12 | 2008 |
Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis.
Topics: Adult; Amino Acids, Sulfur; Aminoisobutyric Acids; Cysteine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1980 |
Net uptake of plasma homocysteine by the rat kidney in vivo.
Topics: Animals; Blood Flow Velocity; Diuresis; Glomerular Filtration Rate; Homocysteine; Kidney; Kidney Failure, Chronic; Male; Rats; Rats, Sprague-Dawley; Renal Artery; Renal Circulation; Renal Veins | 1995 |
Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Confidence Intervals; Embolism, Cholesterol; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Prevalence; Renal Dialysis; Risk Factors; Serine; Vitamin B Complex | 1995 |
Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cysteine; Dipeptides; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Renal Dialysis; Sulfhydryl Compounds | 1995 |
Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation.
Topics: Adult; Aged; Betaine; Fasting; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Treatment Failure | 1995 |
Withdrawal of folic acid supplementation in maintenance hemodialysis patients.
Topics: Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Renal Dialysis | 1994 |
Plasma homocysteine in renal failure.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1993 |
Renal metabolism of homocysteine in vivo.
Topics: Animals; Biological Transport, Active; Cardiovascular Diseases; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Rats; Renal Plasma Flow | 1995 |
Increased serum level of total homocysteine in CAPD patients despite fish oil therapy.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Blood Viscosity; Creatinine; Cytokines; Female; Fish Oils; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Risk Factors | 1996 |
Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Topics: Adult; Aged; Amino Acid Sequence; Cardiovascular Diseases; Cholesterol, HDL; Comorbidity; Creatinine; DNA Mutational Analysis; Female; Folic Acid; Glucose Intolerance; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Peritoneal Dialysis; Polymorphism, Restriction Fragment Length; Prevalence; Renal Dialysis; Risk Factors; Smoking; Vitamin B 12 | 1996 |
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.
Topics: Adult; Age Factors; Aged; Amino Acid Metabolism, Inborn Errors; Arteriosclerosis; Biomarkers; Blood Coagulation Disorders; Case-Control Studies; Epidemiologic Factors; Female; Fibrinogen; Homocysteine; Humans; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Renal Dialysis; Risk Factors; Sex Factors | 1996 |
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
Topics: Aged; Aging; Arteriosclerosis; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Osmolar Concentration; Peritoneal Dialysis, Continuous Ambulatory; Pyridoxine; Renal Dialysis; Risk Factors; Sex Distribution; Vitamin B 12 | 1996 |
Homocysteine and folate concentrations in blood from patients treated with hemodialysis.
Topics: Adult; Aged; Erythrocytes; Erythropoietin; Female; gamma-Glutamyl Hydrolase; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Spectrophotometry | 1996 |
Homocysteine - a new arteriosclerotic risk factor in end-stage renal failure.
Topics: Arteriosclerosis; Cystathionine beta-Synthase; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Risk Factors | 1997 |
Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.
Topics: Adult; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kinetics; Male; Methionine; Middle Aged | 1997 |
Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.
Topics: Adult; Aged; Arteriosclerosis; Fasting; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methionine; Middle Aged; Pyridoxine | 1997 |
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
Topics: Adult; Aged; Arteriosclerosis; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cohort Studies; Comorbidity; Diabetes Mellitus; Fasting; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Proportional Hazards Models; Prospective Studies; Pyridoxine; Renal Dialysis; Single-Blind Method; Smoking; Treatment Outcome; Vitamin B 12 | 1997 |
Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Disease-Free Survival; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Risk Factors | 1998 |
Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients.
Topics: Adult; Aged; Fasting; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Renal Replacement Therapy | 1998 |
[Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids].
Topics: Administration, Oral; Adult; Aged; Fatty Acids, Unsaturated; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1998 |
Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?
Topics: Adult; Aged; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Middle Aged; Models, Biological; Renal Dialysis; S-Adenosylhomocysteine; S-Adenosylmethionine | 1998 |
Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease.
Topics: Adult; Aorta; Aortic Diseases; Arteries; Biomechanical Phenomena; Calcinosis; Carotid Arteries; Echocardiography; Elasticity; Endothelins; Female; Femoral Artery; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pulsatile Flow; Radial Artery; Tibial Arteries | 1998 |
The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Renal Dialysis | 1998 |
No net renal extraction of homocysteine in fasting humans.
Topics: Aged; Amino Acids; Creatinine; Fasting; Female; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 1998 |
Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients.
Topics: Arteriosclerosis; Brachial Artery; Case-Control Studies; Endothelium, Vascular; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Risk Factors; Thrombosis; Vasodilation | 1998 |
The relationship between plasma homocysteine and amino acid concentrations in patients with end-stage renal disease.
Topics: Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Amino Acids, Essential; Cross-Sectional Studies; Cysteine; Female; Histidine; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Reference Values | 1998 |
Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Topics: Adult; Female; Folic Acid; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxine; Renal Dialysis; Vitamin B 12 | 1998 |
Serum total homocysteine concentration before and after renal transplantation.
Topics: Adult; Aged; Arteriosclerosis; Case-Control Studies; Cyclosporine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Risk Factors; Time Factors | 1998 |
Acquired hyperhomocysteinemia in heart transplant recipients.
Topics: Heart Transplantation; Homocysteine; Humans; Kidney Failure, Chronic; Metabolic Diseases; Postoperative Complications | 1998 |
Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
Topics: Antibodies, Anticardiolipin; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Catheters, Indwelling; Female; Homocysteine; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Thrombosis | 1999 |
The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass.
Topics: Adipose Tissue; Adult; Amino Acids; Analysis of Variance; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Creatinine; Dialysis Solutions; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Size; Peritoneal Dialysis; Triglycerides; Uremia | 1999 |
Hyperhomocyst(e)inaemia in children with chronic renal failure.
Topics: Adolescent; Child; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Homocystine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Postoperative Period; Severity of Illness Index | 1999 |
Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Topics: Adult; Erythrocytes; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Renal Dialysis | 1999 |
Cerebral vascular complication and hyperhomocysteinemia in a cystinotic uremic child.
Topics: Adolescent; Cerebrovascular Disorders; Cystinosis; Female; Homocysteine; Humans; Kidney Failure, Chronic | 1999 |
Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
Topics: Creatinine; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Peritoneal Dialysis; Prevalence; Pyridoxine; Renal Dialysis; Smoking; Time Factors; Vitamin B 12 | 1999 |
Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Ascitic Fluid; Creatinine; Dialysis Solutions; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1999 |
Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
Topics: Adult; Aged; Dietary Supplements; Female; Folic Acid; Folic Acid Antagonists; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Vitamin B 12 | 1999 |
Lipid-lowering drugs and homocysteine.
Topics: Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged | 1999 |
Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5 mg daily.
Topics: Aged; Arteriosclerosis; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors | 1999 |
Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease.
Topics: Cross-Sectional Studies; Female; Folic Acid; Gene Frequency; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Renal Dialysis; Vitamin B 12 | 1999 |
The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
Topics: Adult; Aged; Blood Pressure; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prospective Studies | 1999 |
Homocysteine and methionine metabolism in ESRD: A stable isotope study.
Topics: Adult; Aged; Carbon Isotopes; Cardiovascular Diseases; Case-Control Studies; Deuterium; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kinetics; Male; Methionine; Methylation; Middle Aged; Renal Dialysis; Risk Factors | 1999 |
Ocular venous occlusion and hyperhomocysteinemia.
Topics: Homocysteine; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Retinal Vein; Venous Thrombosis | 1999 |
Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Topics: Aged; Arteriosclerosis; Coronary Artery Disease; Cross-Sectional Studies; Erythrocytes; Female; Folic Acid; Homocysteine; Homocystine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Renal Dialysis; Retrospective Studies; Risk Factors; Sex Factors; Vitamin B 12 | 1999 |
Reversal of hyperhomocyst(e)inaemia in chronic renal failure-is folic or folinic acid the answer?
Topics: Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Leucovorin | 1999 |
Evidence of altered homocysteine metabolism in chronic renal failure.
Topics: Arteriosclerosis; Citrates; Creatinine; Cystathionine; Cysteine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; Renal Dialysis; Risk Factors; Vitamins | 1999 |
Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis.
Topics: Aged; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum | 1999 |
[Hyperhomocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine].
Topics: Adult; Biological Transport; Circadian Rhythm; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum | 1999 |
The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Deficiency Diseases; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Renal Dialysis; Risk Factors; Vascular Diseases | 2000 |
An increased serum level of free Apo(a) in renal patients is more striking than that of Lp(a) and is influenced by homocysteine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoproteins A; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Linear Models; Lipoprotein(a); Male; Middle Aged; Nephrotic Syndrome; Peritoneal Dialysis; Renal Dialysis | 2000 |
Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
Topics: Adult; Aged; Animals; Case-Control Studies; Chromatography, High Pressure Liquid; Erythrocytes; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Time Factors; Tissue Distribution; Vascular Diseases | 2000 |
The significance of serum homocysteine levels in diabetic patients on haemodialysis.
Topics: Aged; Arteriosclerosis; Biomarkers; Creatinine; Diabetic Angiopathies; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Risk Factors; Serum Albumin | 2000 |
Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Topics: Acute-Phase Proteins; Adult; Aged; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Metalloproteins; Middle Aged; Prevalence; Regression Analysis; Renal Dialysis; Risk Factors | 2000 |
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.
Topics: Adult; Aged; Antibodies, Bacterial; C-Reactive Protein; Carotid Artery Diseases; Chlamydia Infections; Chlamydophila pneumoniae; Female; Fibrinogen; Homocysteine; Humans; Immunoglobulin G; Kidney Failure, Chronic; Lipoprotein(a); Male; Membranes, Artificial; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Predictive Value of Tests; Regression Analysis; Renal Dialysis; Ultrasonography, Doppler, Color; Uremia | 2000 |
[Homocysteine and its metabolites in chronic renal insufficiency and the effect of a vitamin replacement].
Topics: Adult; Aged; Arteriosclerosis; Cysteine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Pyridoxine; Renal Dialysis; Severity of Illness Index; Vitamin B 12; Vitamin B Complex | 2000 |
A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Cysteine; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Regression Analysis; Renal Dialysis | 2000 |
Oral folate reduces plasma homocyst(e)ine levels in hemodialysis patients with cardiovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Dietary Supplements; Female; Folic Acid; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2000 |
Folic acid and pyridoxal-5'-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation.
Topics: Cross-Sectional Studies; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxal Phosphate; Renal Dialysis; Solubility; Vitamin B Complex | 2000 |
Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Fasting; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Korea; Male; Middle Aged; Prevalence; Pyridoxal Phosphate; Serum Albumin; Vitamin B 12 | 2000 |
Effect of homocysteine on carotid intima-media thickness after renal transplantation.
Topics: Adult; Arteriosclerosis; Carotid Artery, Common; Female; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2000 |
Plasma reduced homocysteine concentrations are increased in end-stage renal disease.
Topics: Adult; Chromatography; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Kidney Failure, Chronic; Osmolar Concentration; Oxidation-Reduction; Reference Values; Renal Dialysis | 2001 |
Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?
Topics: Adult; Aged; Arteriosclerosis; Brachial Artery; Carotid Artery, Common; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperemia; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Nitroglycerin; Risk Factors; Tunica Intima; Ultrasonography | 2001 |
Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease.
Topics: Aged; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Vascular Diseases | 2001 |
Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
Topics: Adult; Aged; Alleles; Carotid Artery Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Gene Frequency; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Renal Dialysis | 2001 |
Simultaneous determination of total plasma glutathione, homocysteine, cysteinylglycine, and methionine by high-performance liquid chromatography with electrochemical detection.
Topics: Aging; Calibration; Chromatography, High Pressure Liquid; Diabetes Mellitus; Dipeptides; Female; Glutathione; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Quality Control; Reference Values; Risk Factors; Sensitivity and Specificity | 2001 |
Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Betaine; Betaine-Homocysteine S-Methyltransferase; Creatinine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methyltransferases; Middle Aged; Peritoneal Dialysis; Predictive Value of Tests; Pyridoxine; Renal Dialysis; Sarcosine; Uremia; Vitamin B 12; Zinc | 2001 |
Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
Topics: Adult; Aged; Dialysis; Female; Folic Acid; Gene Frequency; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Peritoneal Dialysis; Polymorphism, Genetic; Renal Dialysis; Vitamin B 12 | 2001 |
Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
Topics: Amino Acids; Erythrocytes; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Renal Dialysis; Vitamin B 12 | 2001 |
Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
Topics: Adult; Aged; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Diabetes Complications; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Japan; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Outcome Assessment, Health Care; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prospective Studies; Risk Factors; Ultrasonography | 2001 |
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, HDL; Cohort Studies; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus; Female; Hemoglobin A; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Peripheral Vascular Diseases; Prevalence; Prospective Studies | 2001 |
The fibrinolytic system in chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinolysis; Homeostasis; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 2001 |
Total plasma homocysteine and related amino acids in end-stage renal disease (ESRD) patients measured by gas chromatography-mass spectrometry--comparison with the Abbott IMx homocysteine assay and the HPLC method.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amino Acids; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Models, Chemical; Reference Values; Sex Factors | 2001 |
Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidoreductases Acting on CH-NH Group Donors; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renal Dialysis; Risk Factors; Statistics as Topic; Vitamin B 12 | 2002 |
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Factors | 2002 |
Plasma aminothiol oxidation in chronic hemodialysis patients.
Topics: Adult; Blood Proteins; Cysteine; Glutathione; Homocysteine; Humans; Kidney Failure, Chronic; Middle Aged; Oxidation-Reduction; Oxidative Stress; Protein Binding; Renal Dialysis; Uremia | 2002 |
Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients.
Topics: Analysis of Variance; Chi-Square Distribution; Cross-Over Studies; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Riboflavin; Thiamine | 2002 |
Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Topics: Cross-Sectional Studies; Dietary Supplements; Female; Folic Acid; Folic Acid Deficiency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Renal Dialysis; Vitamin B 12; Vitamin B 12 Deficiency | 2002 |
Hyperhomocysteinemia and the risk of thromboembolic phenomenon in patients with chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Thromboembolism | 2002 |
The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
Topics: Adult; Chi-Square Distribution; Female; Folic Acid; Heterozygote; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Renal Dialysis; Statistics, Nonparametric; Vitamin B 12 | 2002 |
Homocysteine and vascular access thrombosis in hemodialysis patients.
Topics: Adult; Aged; Arteriovenous Fistula; Catheters, Indwelling; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Time Factors; Venous Thrombosis | 2002 |
Renal function, homocysteine, and other plasma thiol concentrations during the postrenal transplant period.
Topics: Adolescent; Biomarkers; Cadaver; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Postoperative Period; Sulfhydryl Compounds; Tissue Donors | 2002 |
Homocysteine and C-reactive protein levels in haemodialysis patients.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Vitamin B 12 | 2001 |
Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide.
Topics: Amino Acids, Sulfur; Creatinine; Cysteine; Cystine; Dipeptides; Disulfides; Female; Homocysteine; Humans; Kidney Failure, Chronic; Leucine; Male; Methionine; Middle Aged; Phenylalanine; Taurine; Tyrosine | 1979 |
Increased plasma homocysteine concentration in patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Risk Factors; Uremia | 1992 |
Concentrations of total homocysteine in plasma in chronic renal failure.
Topics: Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged | 1990 |
Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease.
Topics: Adult; Creatinine; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Vascular Diseases | 1988 |
Plasma amino acid abnormalities in chronic renal failure.
Topics: Adult; Amino Acids; Cysteine; Cystine; Disulfides; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Phenylalanine; Renal Dialysis; Tyrosine | 1972 |